药食同源
药食同源的概念内涵、历史源流与中医食疗(药膳)理论体系
这批文献不针对具体成分或疾病,而是从“药食同源/药食兼用”的定义界定、历史脉络、中医养生与食疗药膳理论(如温脾健胃食疗、辨证施膳原则)及临床应用规范等宏观层面阐释其理论内核,构成整份报告的概念与知识起点。
- Transformation from traditional medicine-food homology to modern food-medicine homology(D. Sun-Waterhouse, Xiao-Yu Chen, Zhen-Hua Liu, Geoffrey I. N. Waterhouse, Wen-yi Kang, 2024, Food & Medicine Homology)
- A review of medicine and food homology on traditional Chinese medicine as functional food(Siu Kan Law, Dawn Chingtung Au, 2025, Food & Medicine Homology)
- [Traditional Chinese medicine health care from "long term taking" drugs in Shen Nong's Classic of Materia Medica].(Qian Yu, P. Zhou, Jian-Jun Zhang, Lin-Yuan Wang, Peng-Wei Zhuang, Yan-Jun Zhang, 2023, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica)
- RECORDS OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES Phytochemistry and Pharmacological Effects of Plants in Genus Sonchus (Asteraceae)(H. Fouad, Eman S. Habib, Safwat Ahmed, 2020, No journal)
- Spleen-warming and stomach-benefiting food therapy traditional Chinese medicine composition, spleen-warming and stomach-benefiting food therapy grilled chicken or food therapy meat and manufacture method thereof(Chun-Xiang Zhou, Jing-Hua Jin, 2012, No journal)
- Food therapy and medical diet therapy of Traditional Chinese Medicine(Qun-Li Wu, Xiao-Chun Liang, 2018, Clinical Nutrition Experimental)
- Traditional Chinese Medicine, Food Therapy, and Hypertension Control: A Narrative Review of Chinese Literature.(P. Zou, 2016, The American Journal of Chinese Medicine)
- The Application of Traditional Chinese Medicine Food Therapy Combined with Baduanjin in the Nursing of Constipation Patients(2021, Foreign Language Science and Technology Journal Database Medicine and Health)
资源开发、产业化发展策略与法规准入/安全性有效性评价体系
文献聚焦药食同源从“传统经验”走向“产业产品”的制度与路径问题:资源普查与开发利用现状、行业现状评估与发展策略,以及植物药、营养保健品与功能性食品在不同国家和地区的注册准入、安全性与有效性评价框架及毒理与监管缺口。
- Progress on the resources and exploitation of medicinal edible plants in Hainan Island(W. Qin, 2015, Journal of Guangdong Pharmaceutical University)
- [Research,evaluation,industry status and development strategy of traditional Chinese medicine functional food].(Rong Sun, Xiaotian Qi, Guang-Yao Chen, Gui-min Zhang, Er-Ping Xu, M. Miao, Na-Na Huang, Jin-bo Wang, 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica)
- Management, Safety, and Efficacy Evaluation of Nutraceutical and Functional Food: A Global Perspective(Feibiao Shan, Le Liu, Ling Li, Wen-Le Wang, Ya-Qiong Bi, Min-Hui Li, 2025, Comprehensive Reviews in Food Science and Food Safety)
- Phyto-Pharmaceuticals, Nutraceuticals and Their Evaluation(P. Mukherjee, 2019, Quality Control and Evaluation of Herbal Drugs)
- Safety assessment, toxicological concerns, and regulatory frameworks governing herbal and fruit teas: A Mini Review.(D. T. Otolowo, B. Iguh, V. Jideani, 2026, Journal of Food Protection)
民族植物学调查与地方性药食两用植物传统知识
共同采用民族植物学/人类生态学调查方法,记录特定民族或地区(如达斡尔族、埃塞俄比亚Bako Tibe、泰国与地中海—北非地区)药食两用野生植物的利用方式、加工经验与系统发育背景,为药食同源新资源挖掘提供地方性知识本底。
- An ethnobotanical survey on the medicinal and edible plants used by the Daur people in China(Ya-qiong Bi, Feng Gao, Jing-Xia Guo, Xia Yao, Ai-Ping Wang, Haolin Liu, Yahong Sun, Ru-Yu Yao, Min-Hui Li, 2024, Journal of Ethnobiology and Ethnomedicine)
- Ethnobotanical survey of multipurpose, medicinal and wild edible plants in the upper Gibe watershed landscapes, West Shewa zone, Ethiopia(Misganaw Meragiaw, Mekbib Fekadu, Feyera Senbeta, S. Demissew, 2024, Plant Biosystems)
- A Preliminary Study of Traditional,Wild Medicinal,Edible Plants in Xishuangbanna,Yunnan,China(Wen-Yao Gu, 2014, Plant Diversity and Resources)
- Phylogenetic Perspectives and Ethnobotanical Insights on Wild Edible Plants of the Mediterranean, Middle East, and North Africa(M. Alrhmoun, Naji Sulaiman, A. Pieroni, 2025, Foods)
单味药食同源物种的系统评述:植物学分类、传统应用、化学成分与药理活性
均为“一物一综述”式的专题研究(荠菜、丁香、甘草属、芡实、奇蒿、金线莲、灵芝、药食同源香辛料草本、泰国本土食用蔬菜及地中海野生食用植物等),系统梳理植物学特征、传统食用与药用经验、phytochemistry、药理作用与产业化前景,属资源—品种维度的物质基础梳理。
- Traditional Uses, Bioactive Compounds, and New Findings on Pharmacological, Nutritional, Cosmetic and Biotechnology Utility of Capsella bursa-pastoris(A. Łukaszyk, I. Kwiecień, A. Szopa, 2024, Nutrients)
- Eugenia caryophyllata Thunb.: A comprehensive review of the traditional uses, phytochemistry, pharmacology, and quality control.(Xing Yang, Jihang Xie, Si-Jing Su, Jinyi Wu, Le-Xing Wang, Wan-Qiu Peng, Yi Zhang, 2026, Journal of Ethnopharmacology)
- New insights of licorice (Glycyrrhiza genus) as a functional food.(Lulu Shao, Bailin Li, Yueming Jiang, Bao Yang, 2025, Food Chemistry)
- The Ethnopharmacological, Phytochemical, and Pharmacological Review of Euryale ferox Salisb.: A Chinese Medicine Food Homology(Jiahui Jiang, Haiyan Ou, Rui-Ye Chen, Huiyun Lu, Long-Jian Zhou, Zhiyou Yang, 2023, Molecules)
- Artemisia anomala S. Moore: A review of botany, traditional uses, phytochemistry, pharmacology and quality control.(Junyu Liu, P. Xiong, Lehong Huang, Wei Zhang, Li Song, Heng-Chang Hu, Bo Jia, Xing-Long Liu, 2023, Journal of Ethnopharmacology)
- Current advances on the phytochemistry, pharmacology, quality control and applications of Anoectochilus roxburghii(Xiao-Xue Zou, Kexin Zhang, Xue-Zhen Li, Yu-Qin Zhang, Li-Xia Chen, Hua Li, 2025, Frontiers in Pharmacology)
- A Review of Bioactive Components and Pharmacological Effects of Ganoderma lucidum(Si-Zhu Ren, Hua Liu, Qing Sang, Meng Lu, Qing Gao, Wen-Jie Chen, 2025, Food Science & Nutrition)
- Nutritional values, bioactive compounds, and biological activities of some edible indigenous plants from Thailand(W. Usawakesmanee, S. Siripongvutikorn, Rungnapa Anankarnkit, 2025, Italian Journal of Food Science)
- Exploring the therapeutic potential of bioactive compounds in spices and herbs: Preclinical evidence and medicinal applications(S. Vasanthkumar, T. Prabhu, S. Shenbagavalli, J. Rajangam, S. Kannan, A. Baskaran, 2024, Annals of Phytomedicine An International Journal)
- “Medicine food homology” plants in the treatment of diabetic nephropathy: pathogenic pathways and therapeutic approaches(Zhong-Hong Yan, Dan-Mai Zhao, Xiao-Tian Wang, Rui Zhong, Bei Ding, 2025, Food & Medicine Homology)
可食花卉、药用芽苗与特色植物资源(沙棘、当归等)的功能成分评价
这批文献不以单一药材的传统考证为主,而着眼于“新资源挖掘与功能评价”:15种传统可食花卉的神经活性与抗氧化抗炎潜力、药用植物芽苗阶段酚类与黄酮富集的价值、沙棘多糖的提取纯化—结构表征—心血管与免疫活性及市场趋势、当归挥发油/阿魏酸/多糖的药理与临床应用。
- Traditionally Used Edible Flowers as a Source of Neuroactive, Antioxidant, and Anti-Inflammatory Extracts and Bioactive Compounds: A Narrative Review(Maciej Książkiewicz, Michalina Karczewska, Filip Nawrot, K. Korybalska, E. Studzińska-Sroka, 2025, Molecules)
- Therapeutic potential of medicinal plant sprouts: emerging opportunities and challenges in phytochemistry(Dominika Melegová, Andrea Babelova, Michal Šelc, 2025, Planta)
- Medicinal and edible polysaccharides from ancient plants: extraction, isolation, purification, structure, biological activity and market trends of sea buckthorn polysaccharides.(Xinmei Xu, Xianfeng Liu, Shufu Yu, Ting Wang, Rui Li, Yi Zhang, Yue Liu, 2024, Food & Function)
- Chemical Composition, Pharmacological Effects, and Clinical Applications of Danggui (Angelicae Sinensis Radix)(Jiao Wu, Jialong Zhang, Fang-Chao Tong, Haichuan Yu, 2025, Chinese medicine and natural products)
食用与药用真菌类药食同源资源的成分、功能与产业化开发
均以真菌为对象,形成“资源—成分—功能—应用”闭环:黑木耳栽培可持续性与多糖、黑色素等功能成分,猴头菇营养—风味—猴头菌酮/猴头菌素促NGF的双重价值,麦角甾醇的药理活性与维生素D2前体属性,以及淡水环境药食用真菌的抗菌、抗肿瘤与免疫调节活性。
- Sustainable Cultivation and Functional Bioactive Compounds of Auricularia Mushrooms: Advances, Challenges, and Future Prospects(Miao Liu, Wen-Xin Jiang, Kai Huang, Ling Li, Q. Meng, Xiao-Xu You, Kunlun Pu, M. Cheng, Zhen-Peng Gao, Jian-Zhao Qi, Ming-Lei Li, 2025, Biology)
- Lion's Mane Mushroom: Nutritional Profile, Bioactive Compounds, Functional Properties, and Applications in Functional Food Systems.(Raja Balqis Raja-Razali, Nur Asyiqin Zahia-Azizan, Chong-Shin Yee, Muhammad Ameer Ushidee-Radzi, Z. Ilham, Nazimah Hamid, A. Klaus, Wan Abd al Qadr Imad Wan-Mohtar, 2026, Journal of Food Science)
- Potential Beneficial Effects and Pharmacological Properties of Ergosterol, a Common Bioactive Compound in Edible Mushrooms(Panthakarn Rangsinth, R. Sharika, N. Pattarachotanant, Chatrawee Duangjan, Chamaiphron Wongwan, C. Sillapachaiyaporn, S. Nilkhet, Nichaporn Wongsirojkul, A. Prasansuklab, T. Tencomnao, G. Leung, S. Chuchawankul, 2023, Foods)
- Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds(Ilenia Cicero, G. Mirabile, G. Venturella, 2025, Journal of Fungi)
活性成分(多糖、皂苷、酚酸、类黑精、甘露糖蛋白)的结构表征与构效关系
跨越具体物种,聚焦药食同源物质基础的化学层面:多糖的精细结构解析与功能活性、皂苷的构效关系、酚酸的组成与生物活性、发酵类黑精的形成与功能、酵母甘露糖蛋白的结构异质性,以及加工过程对活性成分变化的影响,属于成分—结构—活性范式研究。
- Saponins Based on Medicinal and Edible Homologous Plants: Biological Activity, Delivery Systems and Its Application in Healthy Foods(Si-Wen Chen, Ying Zhou, Hui-Liang Li, Li-Jun You, S. Pedišić, Ping Shao, 2024, Food Bioengineering)
- Advanced analysis of polysaccharides, novel functional components in food and medicine dual purposes Chinese herbs(Jing Zhao, Yong Deng, Shao-Ping Li, 2017, Trends in Analytical Chemistry)
- Research progress on polysaccharides from medicine and food homology materials in functional foods.(Dejun Hu, Yifan Zhang, Bo-Yao Li, Chong-Jiang Cao, 2025, Chinese Journal of Natural Medicines)
- Progress on the melanoidins produced by the Maillard reaction of fermented food and traditional Chinese medicine(Guangzhen Cao, Si-Yi Zhang, Yaosong Yang, Qing He, Xin Song, Fei Long, Teng Peng, 2024, Food and Health)
- Comprehensive insights into yeast mannoproteins:structural heterogeneity, winemaking, food processing, and medicine food homology.(Bing-Hong Gao, Chuan-Yan Rao, Xingmeng Lei, Siqi Li, Xiao-Chuan Huang, Yan-Lin Liu, Dong-Qing Ye, 2025, Food Research International)
- Phenolic acids from medicinal and edible homologous plants: a potential anti-inflammatory agent for inflammatory diseases(Jing-Chen Xie, Suhui Xiong, Yamei Li, Bo-Hou Xia, Minjie Li, Zhimin Zhang, Zhe Shi, Qiu-Xian Peng, Chun Li, Li-Mei Lin, Duan-Fang Liao, 2024, Frontiers in Immunology)
- Research Progress on the Mechanism for Improving Glucose and Lipid Metabolism Disorders Using Phenolic Acid Components from Medicinal and Edible Homologous Plants(Miao Sun, Zhimin Zhang, Jing-Chen Xie, Jiahui Yu, Suhui Xiong, Feng Xiang, Xinyi Ma, Chen Yang, Li-Mei Lin, 2024, Molecules)
抗炎、抗氧化、免疫调节与抗衰老的共性分子通路机制
这组文献以分子机制而非疾病为线索,围绕NF-κB、MAPK、NLRP3、Nrf2、PI3K-Akt等通路,阐释药食同源植物中黄酮类(黄芩苷、木犀草素)及其他植物化学物的抗炎、抗氧化、免疫炎症调节与抗衰老/延缓细胞衰老作用,是现代药理学的机制解释层。
- Anti-Aging Potential of Bioactive Phytoconstituents Found in Edible Medicinal Plants: A Review(E. Iweala, O. E. Adurosakin, Ugochukwu Innocent, C. Omonhinmin, O. Dania, E. Ugbogu, 2024, The Scientist)
- Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions.(Qian-Ming Kang, Lu-Ying He, Yang Zhang, Zhangfeng Zhong, Wen Tan, 2024, Phytomedicine)
- Mechanisms of Chinese herbal medicine in modulating gut microbiota on primary open-angle glaucoma: a study based on data mining, network pharmacology, and Mendelian randomization(Yu Tang, Bing-Yao Zhu, Qian-Hong Liu, Kai Wu, Pai Zhou, Xiao-Lei Yao, Qing-Hua Peng, 2025, Digital Chinese Medicine)
- Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants.(Yun-Fei Zhu, An-Guo Wu, Meng-Yi Chen, Xing-Yue Zhou, Fei-Hong Huang, Long Wang, Lu Yu, Yong-Ping Wen, Da-Lian Qin, Jian-Ming Wu, Xiao-Gang Zhou, 2025, Phytomedicine)
- Baicalin: bridging traditional medicine and modern science in food and functional applications(Chen-qin Xu, Yi-Lang Zhong, Tao Liu, Xiao-Hui Yang, Miao-Miao Wang, Chuang Ke, Yong-Bing Cao, Jian Chen, 2025, Naunyn-Schmiedeberg's Archives of Pharmacology)
- Luteolin: A Dietary Molecule as Potential Anti-COVID-19 Agent(W. Ansari, Tanveer Ahamad, M. Khan, Z. A. Khan, M. Khan, 2020, No journal)
糖脂代谢紊乱与代谢综合征(肥胖、糖尿病、绝经后代谢异常、高尿酸)干预
文献共同关注能量与糖脂代谢紊乱类疾病,涉及枸杞、佛手、茯苓、山楂/决明子等药食同源组合的减重与代谢改善作用,miRNA调控糖尿病及其并发症的分子机制,以及代谢组学解析中药复方对糖脂代谢与高尿酸血症的干预,属同一疾病谱系下的功效验证。
- Supercharging metabolic health with Lycium barbarum L.: A review of the therapeutic potential of this functional food for managing metabolic syndrome(J. Sharifi-Rad, Maria Magdalena Quetglas-Llabrés, A. Sureda, L. Mardones, M. Villagrán, Eda Sönmez Gürer, J. Živković, S. Ezzat, A. Zayed, Safa Gümüşok, Ceyda Sibel Kılıç, Babatunde Fasipe, I. Laher, M. Martorell, 2024, Food Frontiers)
- Finger Citron Fruit Ameliorates Ovariectomy-Induced Postmenopausal Metabolic Syndrome Through Regulation of Lipogenesis and Ferroptosis-Related Alterations.(Xiao-Qin Wu, Ting-Ting Chen, Min Qiu, Wei-Ming Ni, Wei-Ru Liu, Li-Ke Xu, Jia-Wen Huang, Zhuo-Hui Luo, 2026, Journal of Ethnopharmacology)
- Poria cocos as a Functional Food for Diabetes and Diabetes‐Related Foot Ulcers(Yi-San Lee, Tien-Fen Kuo, Greta Yang, Wen-Chin Yang, 2026, AgriFood: Journal of Agricultural Products for Food)
- Mechanism of Weight Loss by Medicine-Food Homology Herbs in Chinese National Patent Herbal Formulae Based on Network Pharmacology(Li-Li Huang, Zhi-Hui Wang, Lei-Lei Zhu, 2025, IEEE International Conference on Bioinformatics and Biomedicine)
- MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks(Jun-Ren Chen, Maozhu Luo, Si-Qi Qin, Cheng Peng, Dan Li, 2025, Phytotherapy Research)
- Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components(Cheng-Yuan Wang, Jian Dai, 2023, Frontiers in Nutrition)
- Research Progress on the Prevention and Treatment of Alcoholic Liver Disease with Medicinal and Edible Herbs.(Shuhua Zhao, Hui Yang, Hua Wu, Zhuo-Ke Li, Na Zheng, Jin Wang, Hong-wen Zhao, Jun-Feng Liu, Ting-Ting Sun, Hong Zhang, 2025, Journal of Ethnopharmacology)
- Metabolomics Mechanistic Exploration of Traditional Chinese Medicine Dietary Intervention for Female Recurrent Urinary Tract Infections Under the Guidance of the “Medicine-Food Homology” Theory(Bingyan Wang, Genping Lei, 2025, Journal of Contemporary Medical Practice)
心血管保护与免疫炎症性疾病的辅助干预证据
以慢性心力衰竭、心血管损伤、动脉粥样硬化相关危险因素及免疫炎症性病症为对象,通过植物化学分析与细胞/动物模型验证、文献叙述性综述等路径评估药食同源植物及其成分的心血管保护与抗炎免疫调节效应,并强调其“膳食辅助”定位与证据等级。
- Exploring natural therapy for chronic heart failure: experience in traditional Chinese medicine treatment before 2022(Liping Pan, Lanxin Zhu, Bing Wang, Yi-Qi Li, Li Gao, Hui-Hui Zhao, 2025, Frontiers in Medicine)
- Phytochemical analysis and cardiovascular protective effect of four herbal medicines with functional food properties (Four Huaiqing Chinese Medicine)(Yan Li, Xiao-Fei Xue, Meng Peng, Xiaolin Zheng, Sen Guo, Hai-Long Tao, 2024, Natural Product Research)
- Diet and Medicinal Herbs as Adjunctive Approaches to Immune Homeostasis in Sjögren’s Disease(Xiaoyu Xu, Jie Yu, Yun Feng, Jing He, Xiang Lin, 2026, International Journal of Molecular Sciences)
- Food-Derived Substances and Edible Chinese Medicinal Materials in Psoriasis Management: Potential, Evidence, and Perspectives-A Narrative Review(Xiao-Qing Ma, Shu-Niu Zheng, Jin-Jin Kai, Xian-Wei Wu, 2026, Clinical, Cosmetic and Investigational Dermatology)
- STUDY OF THE ANTI-IINFLAMMATORY ACTIVITY OF SOME MEDICINAL EDIBLE PLANTS GROWING IN EGYPT(N. Ammar, S. Y. Al Okbi, D. Mohamed, 1997, No journal)
肝、肾、胃肠等代谢与消化器官的靶器官保护作用
以靶器官损伤为组织线索,分别探讨药食同源活性成分对肝脏(脂肪肝、酒精性肝病、肝炎与纤维化)、肾脏(急性肾损伤)及胃黏膜(慢性胃炎)的保护作用及其抗氧化、抗凋亡、抗纤维化机制,突出“食疗保肝护胃”的实证支撑。
- Bioactive Herbs for Liver Disorders: A Phyto-Pharmacological Review.(Poonam Sahu, T. Satapathy, 2025, Current drug metabolism)
- A review: hepatoprotective compounds and its mechanism of medicine-food homology resources(Qing Hu, Shuang-Shuang Zhang, Jun-Shang Liu, Ya-Li Liu, Xiaoyu Chen, Jinmei Wang, 2025, Agricultural Products Processing and Storage)
- Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury(Ling Chen, Yanyan Deng, Jing Hu, Xue-Zhong Gong, 2025, Frontiers in Pharmacology)
- Role of Bioactive Ingredients from Medicine Food Homology Species in the Regulation of Chronic Gastritis(Dan-Xi Yan, L. Zhuang, B. Deng, Xi-Chen-Hui Qiu, Zi-Yun Zeng, Yuxuan Zhang, Jie-Shu You, 2025, Natural Product Communications)
神经退行性与神经精神疾病(AD、PD、抑郁、脑缺血再灌注)的神经保护机制
文献以中枢神经系统为共同靶域:山茱萸单体四氢鸭脚木碱的神经保护、药食同源小分子多靶点抑制剂治疗AD的机制、药食同源活性成分在帕金森病中的作用、药用食用植物抗抑郁的机制研究,以及中药对脑缺血再灌注损伤的保护,方法上多为网络药理学+分子对接+体外/体内验证。
- Bioactive compounds from Chinese herbal plants for neurological health: mechanisms, pathways, and functional food applications(Meng Wang, Chao Wang, Kai-Wei Zhao, Si-Jia Ma, Jiajia Sang, Shijie Xu, 2025, Frontiers in Nutrition)
- Traditional Chinese Medicine for Cerebral Ischemia-Reperfusion Injury Prevention: Molecular Mechanisms and Future Perspectives.(Liu-Ding Wang, Yifan Chen, Yue Liu, Jing-Jing Wei, Lina Miao, Ze Chang, Min Jia, Longtao Liu, Xiao Liang, Yun-Ling Zhang, 2025, The American Journal of Chinese Medicine)
- Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of Aβ1-42 and tau through regulation of PI3K/Akt signaling pathway.(Kang Chen, Gu-Ran Yu, 2023, European Journal of Pharmacology)
- Therapeutic Mechanisms of Medicine Food Homology Plants in Alzheimer’s Disease: Insights from Network Pharmacology, Machine Learning, and Molecular Docking(Shuran Wen, Ye Han, You-Gui Li, Dong-Ling Zhan, 2025, International Journal of Molecular Sciences)
- Medicine–food homology bioactives in Parkinson’s disease: multi-target oxidative-stress modulation and translation to dietary supplements(Meng Wang, Yi-Zhu Zhang, Qiong Wu, Si-Jia Ma, Chao Wang, Jiajia Sang, 2025, Frontiers in Nutrition)
- Medicinal-Edible Plants in Depression Therapy: Mechanistic Basis, Bioactive Compounds, and Translational Perspectives(Guang-Yu Zhang, Li Gao, Haixia Ji, Taotao Zhang, Xiao-Kai Ma, Ying-Hu Zhao, 2026, Revista Brasileira de Farmacognosia)
肠道菌群—代谢物—宿主轴的机制框架与“后益生菌”范式
这组文献偏重机制框架与综述性建构:以短链脂肪酸、胆汁酸等菌群代谢物及线粒体为中介,阐释中药/药食同源经肠—脑、肠—肝、肠—肺等远端轴发挥效应的路径,并反思传统益生菌范式,提出菌群作为治疗靶点与“草本是超越益生菌的干预手段”等理论主张。
- The role of gut microbiota mediated ferroptosis in PCOS and the therapeutic potential of Chinese herbal medicine(Ying-Chun Lv, Dong-Qi Li, Ning Ding, H. Kuang, 2026, Frontiers in Medicine)
- Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review(Yu-Juan Li, Sheng-Jie Yang, Xiao Jin, Dan Li, Jing-Ning Lu, Xin-Yue Wang, Min Wu, 2023, Frontiers in Pharmacology)
- Herbal medicine and its impact on the gut microbiota in colorectal cancer(Fan Bu, Yifeng Tu, Zi'ang Wan, S. Tu, 2023, Frontiers in Cellular and Infection Microbiology)
- Role of herbal medicine and gut microbiota in the prevention and treatment of obesity.(Qiao Zhang, Yaya Bai, Wen-Xiao Wang, Jia-jia Li, Li Zhang, Yu-Ping Tang, S. Yue, 2023, Journal of Ethnopharmacology)
- Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management(Y. Guan, Guo-Hua Tang, Lei Li, J. Shu, Yuhua Zhao, Li Huang, Jun Tang, 2024, Archives of pharmacal research)
- Chinese Herbal Medicine Targets Gut Microbiota to Combat Neurodegenerative Diseases: Potential Mechanisms and Clinical Implications(Xi Yang, Yanlin Qin, Wen-Xin Mu, Wei Gao, Qi Chen, J. Xia, Zhaozhao Huang, 2026, Journal of Microbiology and Biotechnology)
- Gut microbiota as a therapeutic target of Chinese herbal medicine in allergic rhinitis: the gut–nasal axis and immunity(Zi-Ye Huang, N. Sun, 2026, Frontiers in Physiology)
- The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review(X. Xue, Hong-Bing Zhou, Jia-Xing Gao, Xinghua Li, Jia Wang, Wan-Fu Bai, Ying-Chun Bai, Liya Fan, Hong Chang, Songli Shi, 2024, Heliyon)
- Herbal medicine beyond probiotics: Yiyi Fuzi Baijiang powder and the holistic regulation of gut microbiota in ulcerative colitis(Hua-Jun Zhang, Shui-Quan Jin, Ding-Jun Cai, Zhi-Peng He, 2026, World Journal of Gastroenterology)
基于菌群与肠屏障调节的疾病干预实证(腹泻、咽炎、高尿酸、炎症性肠病等)
与上一组的框架综述相对,这批文献为具体干预实证:铁皮石斛花多糖经LPS/TLR4通路修复肠屏障改善慢性咽炎、山药多糖的益生元样菌群调节、大建中汤与痛泻要方缓解肠道炎症与腹泻、缺味药材的抗炎与菌群调节配伍研究、膳食诱导的菌群差异决定宿主表型、源自药食两用植物的降尿酸菌株干预。
- Diet-induced differences in gut microbiota determine the responder or non-responder of traditional herbal medicine(Kento Takayama, M. Iseki, Chiho Takahara, Ryoko Tomita, K. Ishihara, Tadashi Hayama, Takashi Tanaka, G. Nonaka, Hirofumi Inoue, 2025, Phytochemistry Letters)
- Daikenchuto, a Japanese herbal medicine, ameliorates experimental colitis in a murine model by inducing secretory leukocyte protease inhibitor and modulating the gut microbiota(S. Ozaka, A. Sonoda, Yoko Kudo, K. Ito, N. Kamiyama, N. Sachi, T. Chalalai, Y. Kagoshima, Y. Soga, S. Ekronarongchai, Shimpei Ariki, K. Mizukami, Shiori Ishizawa, M. Nishiyama, Kazunari Murakami, Kiyoshi Takeda, Takashi Kobayashi, 2024, Frontiers in Immunology)
- Anti‐Inflammatory and Microbiota‐Regulating Property of Deficiency Tonic Medicines in Edible Traditional Chinese Medicine: A Promising Therapy for Depressive Disorder(Siyu Ren, Peilin Qin, Gang Wang, Jian Yang, 2024, Journal of food biochemistry)
- Uricolytic Bacillus from medicinal-edible plants ameliorates hyperuricemia in geese(Chao Wei, Junxuan Cao, Boyang Hu, Ze-Tao Du, Hong-Yu Zhang, Yujie Dai, Aolin Peng, Yanyan Liao, Zhaoxia Zou, Chun-Liang Xie, Jinjun Chen, 2025, Archives of Microbiology)
- Polysaccharides, the Active Component of Dendrobium officinale Flower, Ameliorates Chronic Pharyngitis in Rats via TLR4/NF-κB Pathway Regulation.(Mei-Qiu Yan, Yajuan Tian, Meng Fu, Heng-Pu Zhou, Jing-Jing Yu, Jie Su, Zi-Yan Chen, Z. Tao, Yulong Zhu, Xueling Hu, Jiayi Zheng, Su-Hong Chen, Jianzhen Chen, Gui-Yuan Lv, 2024, Journal of Ethnopharmacology)
- Research progress on the regulation of gut microbiota by Chinese yam polysaccharides(Ting Hu, Peng Wu, Jian-Feng Zhan, Wei-Xin Wang, 2024, Journal of Food Bioactives)
- Synergistic therapy of Chinese herbal medicine and gut microbiota modulation for post-stroke cognitive recovery: focus on microbial metabolite and immunoinflammation(Shi-Hui Ge, Shuang-Li Zhang, Linjing She, Tianning Gu, Shicong Wang, Xin Huang, Lan-Lan Wang, M. Miao, 2025, Frontiers in Microbiology)
- Chinese herbal medicine, Tongxieyaofang, alleviates diarrhea via gut microbiota remodeling: evidence from network pharmacology and full-length 16S rRNA gene sequencing(Haoqing Shao, Liping Wang, Hua-Ling Zhang, 2024, Frontiers in Cellular and Infection Microbiology)
功能食品与药膳产品的配方设计、功能配料与发酵/酿造工艺
聚焦成果产品化环节:蒲公英药膳沙拉的膳食设计、功能性软糖的剂型开发综述、源于中药的生物活性肽配料、抗疲劳复方(杜仲、三七、丁香等)作为功能食品原料的可行性验证,以及五倍子发酵黄酒的理化、风味与微生物群落优化,强调“可食化、可量产”的工艺路径。
- Functional food design of dandelion salad with antibacterial properties(Dawn Chingtung Au, Siu Kan Law, Ching Wong, Mei-Tsz Lai, Amanda Li, H. Wong, 2025, International food research journal)
- [Research progress on functional soft candy of traditional Chinese medicine].(Yan-Hong Wang, N. Luan, Jian Fan, Hong-Jing Li, Kai Sheng, Da-Zhong Chen, 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica)
- Bioactive peptides derived from traditional Chinese medicine and traditional Chinese food: A review.(Ming Liu, Yun-Pu Wang, Yu-Huan Liu, R. Ruan, 2016, Food Research International)
- Feasibility study on the use of “Qi-tonifying medicine compound” as an anti-fatigue functional food ingredient based on network pharmacology and molecular docking(Yi Wu, Yixuan Ma, Jinguo Cao, Rui Xie, Feng Chen, Wen-Ting Hu, Yu-Shan Huang, 2023, Frontiers in Nutrition)
- Physicochemical, Aroma Compounds, Microbial Community, and Antioxidant Capacity of Huangjiu-Based Functional Liqueur Fermented with Edible Herbs(Xiaolei Zhu, Manlu Jin, Xue Zhang, Chunqiao Zhao, Y. Mao, Jian-Di Zhou, Biao Yuan, Yinping Li, C. Shen, Ting Xia, Xiao Xu, Jian Mao, 2026, Foods)
苦味等风味调控、个性化膳食智能推荐与消费者接受度
从“被接受、被坚持”的落地视角出发:药食同源物质苦味识别与掩蔽策略、AIGC驱动的个性化中医食疗方案生成、基于检索增强大语言模型的膳食推荐系统、辨证施膳接受度的关键影响因素提取,以及补充替代医学消费者体验研究,构成感官—算法—行为三位一体的接受度研究。
- Bitterness of Medicine Food Homology Substances: Mechanisms, Identification, and Reduction Strategies(Zhu Tian, Hui-Lin Zhao, Xu-Hui Huang, Xu-Song Wang, Lei Qin, 2025, Food reviews international (Print))
- AIGC-Driven Personalized Traditional Chinese Medicine Dietary Therapy Interactive System: Design and Implementation(Yong-Dan Sheng, Min Li, Li-Jian Yang, 2025, Proceedings of the 2025 2nd International Conference on Artificial Intelligence, Digital Media Technology and Interaction Design)
- Leveraging Retrieval-Augmented Large Language Models for Dietary Recommendations With Traditional Chinese Medicine’s Medicine Food Homology: Algorithm Development and Validation(Hangyu Sha, Fan Gong, Bo Liu, Run-Fen Liu, Hao-Fen Wang, Tian-Xing Wu, 2025, JMIR Medical Informatics)
- Extraction of Key Factors to Determining the Acceptability of Diet Therapy Based on Syndrome Differentiation of Traditional Chinese Medicine(Yan-Song Luo, Chun-Rong Liu, Kong-Fan Qiang, 2022, AHFE International)
- Complementary and Alternative Medicine: Consumers' Experience With Food Therapy in Traditional Chinese Medicine in Hong Kong.(A. Yau, Matthew W. L. Yeung, G. Auyeung, Crystal Lee, 2021, Alternative Therapies in Health and Medicine)
新型递送系统、功能材料与炮制/加工改性技术
聚焦提升活性成分稳定性、靶向性与生物利用度的工程化手段:纳米碳酸钙载百里醌、肠靶向药食同源ACE抑制肽微胶囊、碳点功能材料、中药新型煎煮法与炮制引起成分—活性改变、挤压膨化对功能成分的影响,以及药食同源材料的功效强化策略,形成“资源—加工—功效”转化技术链。
- *The traditional Chinese medicine processing change chemical composition and pharmacological effectiveness: Taking Atractylodes macrocephala Koidz. and honey bran-fried Atractylodes macrocephala Koidz. as examples.(Yi-Wen Hao, Xing Zhang, Xia Lin, Sha-Sha Yang, You Huang, Wen-Jing Lai, Xin Liao, Wan Liao, Chao-Mei Fu, Zhen Zhang, 2024, Phytomedicine)
- Calcium carbonate nanoparticles loaded with thymoquinone derived from medicine food homology plants combined with 5-fluorouracil for colon cancer Treatment: Proteomic and metabolomic insights(X. Deng, M. Z. Abu Bakar, Zhong-Ming Yang, 2025, Food Bioscience)
- Intestinal-targeted medicine-food homology ACE-inhibitory peptide microcapsules ameliorate hypertension in an L-NAME-induced gestational rat model via renin-angiotensin system modulation.(Ping-Yao Cong, Xiao-Dong Li, Lu Liu, 2025, Naunyn-Schmiedeberg's Archives of Pharmacology)
- Synthesis, Application and Prospects of Carbon Dots as A Medicine Food Homology(Si-Qi Huang, Huili Ren, Hongyue Chen, Nuan Wen, Libo Du, Chao-Yu Song, Yu-Guang Lv, 2025, Nanomaterials)
- A novel concoction method of Chinese medicinal and edible plants: probiotic fermentation, sensory and functional composition analysis(Zhengxu An, Tong Ye, Junwei Yu, Hongjun Wu, Peirong Niu, Xiao-Bo Wei, Hui-Yan Liu, Hai-Tian Fang, 2025, Sustainable Food Technology)
- The Impact of Extrusion Cooking on the Physical Properties, Functional Components, and Pharmacological Activities of Natural Medicinal and Edible Plants: A Review(Yao Xu, Fan Jia, Yu-Hang Wu, Jia-Ni Jiang, Tao Zheng, Hui Zheng, Yong Yang, 2025, Foods)
- Medicine food homology materials for promoting resilience against metabolic syndrome: Recent technology advances and challenges(Jia-Ning Liu, P. Lee, Wenjie Wu, Jun-Qing Huang, Dan-Yue Zhao, 2025, Trends in Food Science & Technology)
网络药理学、多组学与数据挖掘方法在药食同源研究中的应用
关注研究方法本身:网络药理学“多成分—多靶点”范式用于食品与药食同源机制研究的可行性与方法学构建、非靶向代谢组学结合网络药理学解析罗汉果等资源不同成熟期与部位的活性成分、基于GEO与网络药理学的抗结直肠癌药食同源药物筛选,以及中医用药规律的数据挖掘。
- Application prospect of traditional Chinese medicine network pharmacology in food science research.(Yuan-Yuan Su, Qiong Bai, Hong-Xun Tao, Bin Xu, 2023, The Journal of the Science of Food and Agriculture)
- Metabolomics combined with network pharmacology reveals the effects of ripening stages and edible parts on bioactive ingredients of Luohan Guo (Siraitia grosvenorii).(Hua-Hong Liu, Zhenni Lan, Yun Zhang, Ziwei Zhao, Yuxin Wu, Xuehui Tang, J. Nie, 2025, Food Research International)
- Screening of medicine-food homology drugs for anti-colorectal cancer based on network pharmacology, molecular docking and in vitro experiments(Zhaoshuang Li, Bizhu Geng, Sha Zhang, Canjun Zhao, Qinyou Ren, Yue Hao, Xinya Wen, Haixiao Liu, Jin Zheng, Liang Cao, 2025, CyTA - Journal of Food)
- Exploring rules of traditional Chinese medicine external therapy and food therapy in treatment of mammary gland hyperplasia with text mining(Shanshan Shen, Yao-Xian Wang, Guang Zheng, D. Jia, A. Lu, Miao Jiang, 2014, IEEE International Conference on Bioinformatics and Biomedicine)
质量标准体系、质量标志物与先进分析表征技术
共同解决“质量一致性”问题:草药制剂标准化与掺伪鉴别、多指标质量标志物的规范与测定、样品前处理技术、仓储与货架期稳定性评价、农药残留(拟除虫菊酯)绿色微萃取检测,以及质谱成像、超灵敏植物化学成分表征等前沿分析技术。
- Advancing herbal medicine: enhancing product quality and safety through robust quality control practices(Hong-Ting Wang, Y. Chen, Lei Wang, Qinghui Liu, Si-Yuan Yang, Cunqin Wang, 2023, Frontiers in Pharmacology)
- Quality control of herbal medicines in hyperlipidaemia: Metabolomics approach(Azliana Abu Bakar Sajak, A. Azlan, F. Abas, H. Hamzah, 2023, International food research journal)
- Quality Control and Evaluation of Herbal Product(I. Ahmad, Satyam Sharma, D. Chaurasia, T. Shukla, 2023, International Journal for Research in Applied Science and Engineering Technology)
- Upgrading of Quality Control for Herbal Medicine Use in South Korea by Introducing an Accreditation System: a brief report(Soo-Hyun Sung, 2024, Journal of Pharmacopuncture)
- Specification and Analysis of Multiple Marker Compounds for Quality Control of Mori Cortex Radicis by HPLC(Kyung Tae Kim, M. Shin, Hee Kim, Wo-On-Cho Chong, Wonjae Lee, E. Woo, K. Kim, J. Kang, 2015, Bulletin of The Korean Chemical Society)
- Sample preparation techniques for quality evaluation and safety control of medicinal and edible plants: Overview, advances, applications, and future perspectives(Ling-Xuan Ma, Lele Yang, Lijun Tang, Yu-Di Wang, Hua Luo, Zhang-Feng Zhong, Wensheng Zhang, Di Chen, Jinchao Wei, Peng Li, Yi-Tao Wang, 2025, Journal of Pharmaceutical Analysis)
- A breakthrough in phytochemical profiling: ultra-sensitive surface-enhanced Raman spectroscopy platform for detecting bioactive components in medicinal and edible plants(Chunjuan Yang, Yue Zhao, Shuang Jiang, Xiaomeng Sun, Xiao-Tong Wang, Zhi-Bin Wang, Yan-Li Wu, Jing Wu, Yang Li, 2024, Microchimica Acta)
- State-of-the-art application of mass spectrometry imaging covering the medicinal and edible plants(Qi Jing, Hong-Da Wang, Xue Li, Dian-Xin Cui, Yuying Zhao, Wei Wang, Ying Hu, Meiting Jiang, Xiu-mei Gao, De-an Guo, Wen-zhi Yang, 2024, Trends in Analytical Chemistry (TrAC))
- Evaluation of stability and quality characteristics of moringa (Moringa oleifera) herbal tea during storage(N. I. E. Jayani, M. R. Hean, N. L. A. Krisnayanthi, R. Islamie, K. C. Rani, N. Parfati, 2022, Food Research)
- Determination of pyrethroid pesticides in medicine-food homology tea via homogeneous liquid-liquid microextraction coupled with high-performance liquid chromatography.(Xiao-Jia Zheng, Yu-Lin Wang, Hong-Li Zhang, Qing-Rong Peng, Xianzhao Zhang, Xu Jing, Fanrong Zhao, Jia-Jun Han, 2025, Food Chemistry)
外源污染物、毒性风险识别与人工智能赋能的智能评价
聚焦安全风险与智能化管控:微生物污染、真菌毒素(如黄曲霉毒素)污染状况与健康风险评估、仓储温湿度与脱毒前处理、吡咯里西啶生物碱的结构注释—半定量—毒性预测,以及近红外光谱结合深度学习、AI赋能的质量控制与多组学交叉验证等智能评价手段。
- Microbial Contaminants Evaluation Of White Pomegranate Peel, Seeds, And Beetroot As Validation Of Herbal Raw Material Quality(M. Ramadhan, Anisatul Rofiidah, Linggar Nirwana, 2025, Biotropika Journal of Tropical Biology)
- Contamination Status and Health Risk Assessment of 73 Mycotoxins in Four Edible and Medicinal Plants Using an Optimized QuEChERS Pretreatment Coupled with LC-MS/MS(Xiaojing Huang, Rui Feng, Qing Hu, Xiu-Hong Mao, Heng Zhou, 2025, Toxins)
- Structural annotation, semi-quantification and toxicity prediction of pyrrolizidine alkaloids from functional food: In silico and molecular networking strategy.(Yaping Xu, J. Li, Hua-Jian Mao, Wei You, Jia Chen, Hua Xu, Jian-Feng Wu, Ying Gong, Lei Guo, Tao Liu, Wu-Ju Li, Bin Xu, Jian-Wei Xie, 2023, Food and Chemical Toxicology)
- Evaluation of Storage Conditions and Pre‐Treatment Methods to Mitigate Aflatoxin Contamination in Commonly Used Chinese Herbal Medicines(Tung-Leong Fong, Tingyuan Xing, Y. Chan, Zi-Xin Feng, Guoyi Tang, Yi-Bin Feng, Cheng Zhang, Ning Wang, 2026, Phytochemicals in Food and Medicine)
- Integrating AI and advanced spectroscopic techniques for precision food safety and quality control(Imane Ziani, Hamza Bouakline, A. El Guerraf, A. El Bachiri, M. Fauconnier, F. Sher, 2024, Trends in Food Science & Technology)
- Application of artificial intelligence in the rapid determination of moisture content in medicine food homology substances.(Meng-Yu Zhang, Bo-Ran Lin, Shu-Di Zhang, Cheng Peng, Chang Li, Ting-Ting Feng, Lian Li, Ao-Li Wu, Chun-Guo Yang, Wen-Tian Wang, Shou-Yao Huang, Lei Nie, Heng-Chang Zang, 2025, Food Chemistry)
- Artificial Intelligence empowered evolution in medicine food homology: Innovations, Challenges, and Future Prospects(Lihui Zhang, Bin-Bin Liao, Dahui Liu, Qi-Yong Jiang, Qing Sun, 2025, Food Bioscience)
合并三组初始化分组(共126篇文献、无重复)后,围绕"药食同源"形成20个并列且互不交叉的章节,按"理论—资源—物质基础—机制—疾病应用—方法—产品—质量"的递进逻辑排布:①药食同源概念内涵、历史源流与中医食疗/药膳理论;②资源开发、产业化策略与法规准入及安全性有效性评价;③民族植物学调查与地方性药食两用植物传统知识;④单味药食同源物种的植物学—化学成分—药理系统评述;⑤可食花卉、药用芽苗与沙棘、当归等特色植物资源的功能成分评价;⑥食用与药用真菌资源的成分、功能与产业化;⑦多糖、皂苷、酚酸、类黑精、甘露糖蛋白等活性成分的结构表征与构效关系;⑧抗炎、抗氧化、免疫调节与抗衰老的共性分子通路机制;⑨糖脂代谢紊乱与代谢综合征干预;⑩心血管保护与免疫炎症性疾病的辅助干预;⑪肝、肾、胃肠等靶器官保护;⑫神经退行性与神经精神疾病的神经保护机制;⑬肠道菌群—代谢物—宿主轴的机制框架与"后益生菌"范式;⑭基于菌群与肠屏障调节的疾病干预实证;⑮功能食品与药膳产品的配方设计与发酵酿造工艺;⑯苦味等风味调控、个性化膳食智能推荐与消费者接受度;⑰新型递送系统、功能材料与炮制/加工改性技术;⑱网络药理学、多组学与数据挖掘方法学;⑲质量标准体系、质量标志物与先进分析表征技术;⑳外源污染物与毒性风险识别及人工智能赋能的智能评价。相较原始分组,本次合并将分散于三组中的"理论/食疗/监管"拆分为理论内核与产业制度两章,把"活性成分化学表征"与"抗炎抗氧化抗衰老机制"解耦,把"肠道菌群"区分为机制框架综述与干预实证两个层次,并补充了单列成章的"递送系统与加工改性"和"风味/消费者接受度",使各章主题更具体、组内同质性更高,全面覆盖126篇文献。
这批文献不针对具体成分或疾病,而是从“药食同源/药食兼用”的定义界定、历史脉络、中医养生与食疗药膳理论(如温脾健胃食疗、辨证施膳原则)及临床应用规范等宏观层面阐释其理论内核,构成整份报告的概念与知识起点。相关文献:D. Sun-Waterhouse et. al, 2024 等 8 篇文献
文献聚焦药食同源从“传统经验”走向“产业产品”的制度与路径问题:资源普查与开发利用现状、行业现状评估与发展策略,以及植物药、营养保健品与功能性食品在不同国家和地区的注册准入、安全性与有效性评价框架及毒理与监管缺口。相关文献:W. Qin et. al, 2015 等 5 篇文献
共同采用民族植物学/人类生态学调查方法,记录特定民族或地区(如达斡尔族、埃塞俄比亚Bako Tibe、泰国与地中海—北非地区)药食两用野生植物的利用方式、加工经验与系统发育背景,为药食同源新资源挖掘提供地方性知识本底。相关文献:Ya-qiong Bi et. al, 2024 等 4 篇文献
均为“一物一综述”式的专题研究(荠菜、丁香、甘草属、芡实、奇蒿、金线莲、灵芝、药食同源香辛料草本、泰国本土食用蔬菜及地中海野生食用植物等),系统梳理植物学特征、传统食用与药用经验、phytochemistry、药理作用与产业化前景,属资源—品种维度的物质基础梳理。相关文献:A. Łukaszyk et. al, 2024 等 10 篇文献
这批文献不以单一药材的传统考证为主,而着眼于“新资源挖掘与功能评价”:15种传统可食花卉的神经活性与抗氧化抗炎潜力、药用植物芽苗阶段酚类与黄酮富集的价值、沙棘多糖的提取纯化—结构表征—心血管与免疫活性及市场趋势、当归挥发油/阿魏酸/多糖的药理与临床应用。相关文献:Maciej Książkiewicz et. al, 2025 等 4 篇文献
均以真菌为对象,形成“资源—成分—功能—应用”闭环:黑木耳栽培可持续性与多糖、黑色素等功能成分,猴头菇营养—风味—猴头菌酮/猴头菌素促NGF的双重价值,麦角甾醇的药理活性与维生素D2前体属性,以及淡水环境药食用真菌的抗菌、抗肿瘤与免疫调节活性。相关文献:Miao Liu et. al, 2025 等 4 篇文献
跨越具体物种,聚焦药食同源物质基础的化学层面:多糖的精细结构解析与功能活性、皂苷的构效关系、酚酸的组成与生物活性、发酵类黑精的形成与功能、酵母甘露糖蛋白的结构异质性,以及加工过程对活性成分变化的影响,属于成分—结构—活性范式研究。相关文献:Si-Wen Chen et. al, 2024 等 7 篇文献
这组文献以分子机制而非疾病为线索,围绕NF-κB、MAPK、NLRP3、Nrf2、PI3K-Akt等通路,阐释药食同源植物中黄酮类(黄芩苷、木犀草素)及其他植物化学物的抗炎、抗氧化、免疫炎症调节与抗衰老/延缓细胞衰老作用,是现代药理学的机制解释层。相关文献:E. Iweala et. al, 2024 等 6 篇文献
文献共同关注能量与糖脂代谢紊乱类疾病,涉及枸杞、佛手、茯苓、山楂/决明子等药食同源组合的减重与代谢改善作用,miRNA调控糖尿病及其并发症的分子机制,以及代谢组学解析中药复方对糖脂代谢与高尿酸血症的干预,属同一疾病谱系下的功效验证。相关文献:J. Sharifi-Rad et. al, 2024 等 8 篇文献
以慢性心力衰竭、心血管损伤、动脉粥样硬化相关危险因素及免疫炎症性病症为对象,通过植物化学分析与细胞/动物模型验证、文献叙述性综述等路径评估药食同源植物及其成分的心血管保护与抗炎免疫调节效应,并强调其“膳食辅助”定位与证据等级。相关文献:Liping Pan et. al, 2025 等 5 篇文献
以靶器官损伤为组织线索,分别探讨药食同源活性成分对肝脏(脂肪肝、酒精性肝病、肝炎与纤维化)、肾脏(急性肾损伤)及胃黏膜(慢性胃炎)的保护作用及其抗氧化、抗凋亡、抗纤维化机制,突出“食疗保肝护胃”的实证支撑。相关文献:Poonam Sahu et. al, 2025 等 4 篇文献
文献以中枢神经系统为共同靶域:山茱萸单体四氢鸭脚木碱的神经保护、药食同源小分子多靶点抑制剂治疗AD的机制、药食同源活性成分在帕金森病中的作用、药用食用植物抗抑郁的机制研究,以及中药对脑缺血再灌注损伤的保护,方法上多为网络药理学+分子对接+体外/体内验证。相关文献:Meng Wang et. al, 2025 等 6 篇文献
这组文献偏重机制框架与综述性建构:以短链脂肪酸、胆汁酸等菌群代谢物及线粒体为中介,阐释中药/药食同源经肠—脑、肠—肝、肠—肺等远端轴发挥效应的路径,并反思传统益生菌范式,提出菌群作为治疗靶点与“草本是超越益生菌的干预手段”等理论主张。相关文献:Ying-Chun Lv et. al, 2026 等 9 篇文献
与上一组的框架综述相对,这批文献为具体干预实证:铁皮石斛花多糖经LPS/TLR4通路修复肠屏障改善慢性咽炎、山药多糖的益生元样菌群调节、大建中汤与痛泻要方缓解肠道炎症与腹泻、缺味药材的抗炎与菌群调节配伍研究、膳食诱导的菌群差异决定宿主表型、源自药食两用植物的降尿酸菌株干预。相关文献:Kento Takayama et. al, 2025 等 8 篇文献
聚焦成果产品化环节:蒲公英药膳沙拉的膳食设计、功能性软糖的剂型开发综述、源于中药的生物活性肽配料、抗疲劳复方(杜仲、三七、丁香等)作为功能食品原料的可行性验证,以及五倍子发酵黄酒的理化、风味与微生物群落优化,强调“可食化、可量产”的工艺路径。相关文献:Dawn Chingtung Au et. al, 2025 等 5 篇文献
从“被接受、被坚持”的落地视角出发:药食同源物质苦味识别与掩蔽策略、AIGC驱动的个性化中医食疗方案生成、基于检索增强大语言模型的膳食推荐系统、辨证施膳接受度的关键影响因素提取,以及补充替代医学消费者体验研究,构成感官—算法—行为三位一体的接受度研究。相关文献:Zhu Tian et. al, 2025 等 5 篇文献
聚焦提升活性成分稳定性、靶向性与生物利用度的工程化手段:纳米碳酸钙载百里醌、肠靶向药食同源ACE抑制肽微胶囊、碳点功能材料、中药新型煎煮法与炮制引起成分—活性改变、挤压膨化对功能成分的影响,以及药食同源材料的功效强化策略,形成“资源—加工—功效”转化技术链。相关文献:Yi-Wen Hao et. al, 2024 等 7 篇文献
关注研究方法本身:网络药理学“多成分—多靶点”范式用于食品与药食同源机制研究的可行性与方法学构建、非靶向代谢组学结合网络药理学解析罗汉果等资源不同成熟期与部位的活性成分、基于GEO与网络药理学的抗结直肠癌药食同源药物筛选,以及中医用药规律的数据挖掘。相关文献:Yuan-Yuan Su et. al, 2023 等 4 篇文献
共同解决“质量一致性”问题:草药制剂标准化与掺伪鉴别、多指标质量标志物的规范与测定、样品前处理技术、仓储与货架期稳定性评价、农药残留(拟除虫菊酯)绿色微萃取检测,以及质谱成像、超灵敏植物化学成分表征等前沿分析技术。相关文献:Hong-Ting Wang et. al, 2023 等 10 篇文献
聚焦安全风险与智能化管控:微生物污染、真菌毒素(如黄曲霉毒素)污染状况与健康风险评估、仓储温湿度与脱毒前处理、吡咯里西啶生物碱的结构注释—半定量—毒性预测,以及近红外光谱结合深度学习、AI赋能的质量控制与多组学交叉验证等智能评价手段。相关文献:M. Ramadhan et. al, 2025 等 7 篇文献
总计 126 篇相关文献
Acute kidney injury (AKI) represents significant medical challenges due to its elevated rates of morbidity and mortality, with limited therapeutic options currently available. Hence, the exploration of novel medicinal treatments for AKI management remains vital. Substances of medicine food homology (SMFH), referring to substances having characteristics of both food and medicine, have been applied in China for thousands years.They could be used for daily diets and body conditioning. Traditional Chinese medicine (TCM), with its naturally derived components and demonstrated effectiveness, presents distinctive benefits in AKI treatment. Numerous studies have shown that SMFH and TCM phytochemicals could function satisfactorily with nephroprotective effects and have a significant effect on alleviating AKI as well as its complications. In this review, the pathogenesis of AKI was illustrated. We concentrated on SMFH and TCM phytochemicals against AKI and tried to summarize the underlying mechanisms in various kinds of AKI, highlighting the crucial phytochemical components in AKI prevention and therapy. Besides, strategies for SMFH and TCM phytochemicals globalization are analysed. This review comprehensively reveals that SMFH and TCM phytochemicals exhibit promising potential for AKI intervention by targeting various signal pathways and targets, which would contribute to AKI’s cognition, preventive treatments, as well as global promotion.
BACKGROUND As a biologically intricate process, aging entails functional impairment and predisposes individuals to chronic conditions. Medicine-food homology (MFH) plants, deeply rooted in traditional Chinese medicine, are increasingly recognized for their potential to delay aging through natural bioactive compounds. STUDY DESIGN We conducted a comprehensive review of 56 MFH plants with documented anti-aging effects, focusing on 83 identified bioactive compounds grouped into 14 chemical categories, including phenols, polysaccharides, glycosides, and proteins. METHODS Relevant studies were retrieved from PubMed, Scopus, Web of Science, and Google Scholar up to December 2024. Keywords included "aging," "anti-aging," "cellular senescence," and the Latin names of MFH plants (e.g., Astragalus membranaceus, Curcuma longa). Inclusion criteria required experimental evidence of anti-aging activity using markers such as ROS, MDA, SA-β-gal, SOD, p16INK4a, and p21Waf1/Cip1 across organisms ranging from yeast to mammals and in vitro systems were considered. Key signaling pathways involved were also analyzed. RESULTS Of the 156 MFH plants screened, 78 showed anti-aging potential, with 56 containing partially characterized active compounds. Phenols were the most prevalent, followed by polysaccharides and glycosides. These compounds primarily exerted effects by modulating oxidative stress and activating signaling pathways such as MAPK and DAF-16/FOXO. Less common constituents, such as carrier oils and naphthalene derivatives, also demonstrated notable efficacy. Clinical evidence supports the beneficial effects of certain MFH-derived compounds-such as curcumin and piperine-on skin aging, cognitive decline, and cardiovascular health. CONCLUSIONS MFH plants offer a promising source of natural anti-aging agents. Their bioactive compounds target multiple aging-related pathways and show potential for development into functional foods or phytotherapeutics. To support their potential in aging-related therapies, it is imperative to conduct more in-depth mechanistic investigations alongside well-designed clinical trials that can substantiate their effectiveness and facilitate their translational application.
Moisture content is crucial in quality testing of medicine food homology substances. This study aimed to present a new modeling method for moisture content based on near-infrared spectroscopy. When comparing three methods of partial least squares regression, support vector regression and convolutional neural network (CNN) to build moisture content prediction models of three different substances, it was found that the accuracy was affected by systematic error and was low. Thus, this study integrated moisture characteristic bands data of three substances and established a universal model. The optimal prediction model was SSA-CNN-BiLSTM. The RMSEP value of test set were 0.3568 %, 0.2057 % and 0.0029 %, and RPD value were 10.26, 2.30 and 5.60, respectively. The innovation of this study was that the above method improved modeling accuracy and efficiency. It eliminated systematic errors when each substance was modeled individually, simplified the modeling process, and expanded the scope of model application.
Abstract Background Traditional Chinese Medicine (TCM) emphasizes the concept of medicine food homology (MFH), which integrates dietary therapy into health care. However, the practical application of MFH principles relies heavily on expert knowledge and manual interpretation, posing challenges for automating MFH-based dietary recommendations. Although large language models (LLMs) have shown potential in health care decision support, their performance in specialized domains such as TCM is often hindered by hallucinations and a lack of domain knowledge. The integration of uncertain knowledge graphs (UKGs) with LLMs via retrieval-augmented generation (RAG) offers a promising solution to overcome these limitations by enabling a structured and faithful representation of MFH principles while enhancing LLMs’ ability to understand the inherent uncertainty and heterogeneity of TCM knowledge. Consequently, it holds potential to improve the reliability and accuracy of MFH-based dietary recommendations generated by LLMs. Objective This study aimed to introduce Yaoshi-RAG, a framework that leverages UKGs to enhance LLMs' capabilities in generating accurate and personalized MFH-based dietary recommendations. Methods The proposed framework began by constructing a comprehensive MFH knowledge graph (KG) through LLM-driven open information extraction, which extracted structured knowledge from multiple sources. To address the incompleteness and uncertainty within the MFH KG, UKG reasoning was used to measure the confidence of existing triples and to complete missing triples. When processing user queries, query entities were identified and linked to the MFH KG, enabling retrieval of relevant reasoning paths. These reasoning paths were then ranked based on triple confidence scores and entity importance. Finally, the most informative reasoning paths were encoded into prompts using prompt engineering, enabling the LLM to generate personalized dietary recommendations that aligned with both individual health needs and MFH principles. The effectiveness of Yaoshi-RAG was evaluated through both automated metrics and human evaluation. Results The constructed MFH KG comprised 24,984 entities, 22 relations, and 29,292 triples. Extensive experiments demonstrate the superiority of Yaoshi-RAG in different evaluation metrics. Integrating the MFH KG significantly improved the performance of LLMs, yielding an average increase of 14.5% in Hits@1 and 8.7% in F1-score, respectively. Among the evaluated LLMs, DeepSeek-R1 achieved the best performance, with 84.2% in Hits@1 and 71.5% in F1-score, respectively. Human evaluation further validated these results, confirming that Yaoshi-RAG consistently outperformed baseline models across all assessed quality dimensions. Conclusions This study shows Yaoshi-RAG, a new framework that enhances LLMs’ capabilities in generating MFH-based dietary recommendations through the knowledge retrieved from a UKG. By constructing a comprehensive TCM knowledge representation, our framework effectively extracts and uses MFH principles. Experimental results demonstrate the effectiveness of our framework in synthesizing traditional wisdom with advanced language models, facilitating personalized dietary recommendations that address individual health conditions while providing evidence-based explanations.
No abstract available
No abstract available
Against the background of the vigorous development of materials science and the deep cross-infiltration in many fields, a new medicine food homology, carbon dots (herein combined and abbreviated as MFH-CDs), has sprung up, showing great potential. This review used ChatGPT 4.0 to collect background information related to carbon dots, focusing on the common rich medicinal and food resources such as Lycium barbarum, Chinese yam, honeysuckle, and Ganoderma lucidum. These carbon dots are synthesized by hydrothermal synthesis, microwave radiation, and pyrolysis, which have the advantages of small particle size, high quantum yield, and low cytotoxicity. Recent studies have found that MFH-CDs have great application potential in biosensors, biological imaging, and drug delivery. In this paper, the characteristics of preparing carbon dots from different medicinal and edible resources and their applications in biology in recent years are reviewed, which provides in-depth guidance for the research and application of carbon dots from medicinal and edible biomass, helps it shine in multidisciplinary fields, and opens a brand-new journey from traditional medicinal and edible culture to cutting-edge technology application.
A green, rapid, and efficient homogeneous liquid-liquid microextraction technique involving the use of bio-based solvent 2-methyltetrahydrofuran was developed to extract deltamethrin, beta-cypermethrin, and bifenthrin from medicine-food homology tea samples, including mint-, ginger-, cinnamon- and chrysanthemum-based tea. Various solvents were screened via a conductor-like screening model, and three superior solvents were optimised and validated. 2-Methyltetrahydrofuran was selected as the extractant and added to the sample, and phase separation was induced with ammonium sulfate, achieving extraction in under 1 min without centrifugation. Mechanistic studies using density functional theory calculations and molecular docking revealed that van der Waals forces and hydrogen bonds dominate the interactions. The method exhibited excellent linearity within the range of 0.005-0.5 μg mL-1 and recoveries between 80.6 % and 109.8 %. The environmental sustainability of the entire process was verified. These results emphasise the methold's potential for applications in the trace analysis of pesticides in diverse food matrices.
Medicine-food homology resources possess distinct therapeutic effects in ameliorating hepatotoxicity induced by exogenous agents (chemicals, drugs, alcohol) and immune-mediated liver injury. In this paper, 60 medicine and food homologous materials in health food for liver injury were obtained using the State Administration for Market Regulation (SAMR) platform, and their effective ingredients for treating liver injury (including triterpenoids and their glycosides, flavonoids, phenols, alkaloids and polysaccharides) were also summarized through the China National Knowledge Network (CNKI) database, Pubmed database and Web of Science database. The structure–activity relationship between the active ingredients and hepatoprotective effects were summarized (triterpenoids and their glycosides: C-17 side chain with α,β-stationary ketones; flavonoids: the planar double bond structure at positions C-2 and 3-3 of the C-ring; polyphenols: o-diphenol hydroxyl). In addition, the hepatoprotective mechanisms of these compounds were reviewed and summarized, including regulating oxidative stress through Nrf2 signaling pathway, inhibiting of inflammation response through NF-κB signaling pathway, regulating of apoptosis and autophagy signaling pathway. This paper provided theoretical basis for the clinical application of medical-food homologous resources in protecting and alleviating liver injury, and promoted the development and application of functional foods with hepatoprotective effects in the future.
Background No proven disease-modifying therapy exists for Parkinson’s disease (PD), and prior single-target antioxidants have shown limited, unsustained benefits, highlighting the need for safe multi-target strategies. Objective To synthesize how medicine–food homology (MFH) compounds from Traditional Chinese Medicine (TCM)—polysaccharides, saponins/triterpenoids, polyphenols, carotenoids, and aromatic phenylpropanoids—modulate oxidative stress and PD-related neurodegeneration, and to outline formulation routes toward dietary-supplement development. Methods We searched PubMed, Web of Science Core Collection, Embase (Ovid), and the Cochrane Library from inception through August 1, 2025 with prespecified concept blocks (“Parkinson’s disease,” “oxidative stress,” Nrf2/ARE, NF-κB, PI3K/Akt, autophagy, and MFH terms). English-language in-vitro, invertebrate, and PD-specific rodent studies, selected epidemiology, and formulation/dose/regulatory reports were narratively appraised; no meta-analysis or tool-based risk-of-bias scoring was performed. Results MFH compounds converge on Nrf2/ARE activation, NF-κB suppression, autophagy promotion, and mitochondrial stabilization; nano-/micro-delivery may improve bioavailability and brain exposure in preclinical models. Evidence is predominantly preclinical, with heterogeneous methods and sparse PD-specific randomized trials; epidemiologic signals are suggestive but non-causal. PD-specific oxidative stress arises from dopamine auto-oxidation, neuromelanin–iron catalysis, and complex-I hypofunction; Latest studies further bind these to ferroptosis-linked lipid peroxidation. Clinical evidence remains sparse and PK-limited for MFH actives (e.g., curcumin, EGCG); dose–response, safety monitoring (including liver signals for catechins), and regulatory constraints frame translation. Conclusion MFH compounds are promising, hypothesis-generating candidates for adjunctive nutrition in PD, pending clinical dose–response and long-term safety validation. No clinical efficacy has been established.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by a gradual decline in cognitive function. Currently, there are no effective treatments for this condition. Medicine food homology plants have gained increasing attention as potential natural treatments for AD because of their nutritional value and therapeutic benefits. In this work, we aimed to provide a deeper understanding of how medicine food homology plants may help alleviate or potentially treat AD by identifying key targets, pathways, and small molecule compounds from 10 medicine food homology plants that play an important role in this process. Using network pharmacology, we identified 623 common targets between AD and the compounds from the selected 10 plants, including crucial proteins such as STAT3, IL6, TNF, and IL1B. Additionally, the small molecules from the selected plants were grouped into four clusters using hierarchical clustering. The ConPlex algorithm was then applied to predict the binding capabilities of these small molecules to the key protein targets. Cluster 3 showed superior predicted binding capabilities to STAT3, TNF, and IL1B, which was further validated by molecular docking. Scaffold analysis of small molecules in Cluster 3 revealed that those with a steroid-like core—comprising three fused six-membered rings and one five-membered ring with a carbon–carbon double bond—exhibited better predicted binding affinities and were potential triple-target inhibitors. Among them, MOL005439, MOL000953, and MOL005438 were identified as the top-performing compounds. This study highlights the potential of medicine food homology plants as a source of active compounds that could be developed into new drugs for AD treatment. However, further pharmacokinetic studies are essential to assess their efficacy and minimize side effects.
ABSTRACT The concept of medicine and food homology (MFH) has occupied an important position in traditional Chinese culture since ancient times, which combines nutritional and medicinal benefits but often exhibits undesirable bitterness, limiting their palatability. In recent years, significant attention has been devoted to identifying and masking bitter compounds in food. Nevertheless, comprehensive investigations into the precise identification of bitterness and effective strategies for its masking or elimination remain under-explored, especially in the context of MFH substances. This review systematically summarizes the sources, signal transduction mechanisms, identification, and mitigation strategies of bitter compounds in MFH substances. Future research should prioritize the structural analysis of uncharacterized bitter compounds and innovate non-destructive debittering approaches to broaden the applications of MFH in the food and healthcare industries. This review provides valuable insights for improving the acceptance of MFH products while retaining their bioactive properties.
Backgrouds Chronic gastritis is a chronic inflammation of the gastric mucosa caused by various etiologies. Many studies in recent years have shown that certain Chinese medicines and their bioactive components possess potential therapeutic effects on chronic gastritis. Methods This review focused on promising medicine food homology species used in China for the prevention and management of chronic gastritis, and their bioactive ingredients and underlying mechanisms were summarized and discussed. Results Finally, flavonoids, saponins, terpenoids, alkaloids and polysaccharides were found to be effective in preventing and/ or managing chronic gastritis by combating Helicobacter pylori infection, reducing the inflammatory response and gastric mucosal irritation, and regulating the intestinal microbiota. Conclusions The review is valuable to future studies and the development of medicine food homology species for the management of chronic gastritis.
Mannoproteins (MPs) are primary constituents of yeast cell walls, which are extensively utilized in the winemaking process, in finished wines, and during wine aging to enhance aroma, stabilize pigments, improve wine body, and reduce astringency. However, existing research has mainly focused on the extraction of MPs and certain oenological properties. A review of the literature indicates that our understanding of the targets and mechanisms influenced by MPs related to winemaking characteristics remains limited. Furthermore, as further research on MPs progresses, it also has beneficial effects in other food processing and food healthcare. Therefore, this evaluation examines MPs from three aspects: extraction methods, corresponding structures, and performances, providing a more comprehensive and critical insight into the structure-activity relationship of MPs. In a word, it outlines the primary applications of MPs in food and aims to provide data support for more precise control over the use of MPs from a structural perspective.
No abstract available
ABSTRACT The concept of medicine – food homology (MFH) is deeply entrenched in Chinese medicine and dietary culture. Given the significant impact of dietary habits on colorectal cancer (CRC), the identification of effective MFH drugs that target this malignancy remains a considerable challenge. This study aimed to screen MFH drugs with potential anti-CRC activity utilizing the GEO gene expression database and network pharmacology approaches. Following the identification of active compounds, molecular docking in conjunction with biological experiments was employed to validate the interactions and mechanisms of the key compounds. Based on the results obtained from MFH drug screening, we provide a comprehensive review of the theory of MFH, the classification of associated drugs, and their mechanisms. This work offers valuable theoretical insights and scientific guidance for the practical application of MFH drugs in patients with colorectal cancer.
No abstract available
Obesity has become a global health issue, while conventional weight-loss drugs such as orlistat are often accompanied by adverse effects. Medicine-food homology (MFH) herbs, including Crataegi Fructus, Cassiae Semen, and Coicis Semen, are characterized by high safety and multi-target regulatory properties. However, their weight-loss mechanisms have not been systematically elucidated. This study collected 613 Chinese patent herbal formulations related to weight loss from the national patent database (1995-2025), involving 98 types of MFH herbs with a total usage frequency of 2,957. A specialized database of weight-loss patent formulations was established. Data mining methods were applied to analyze the frequency, properties, flavors, and meridian tropism of MFH herbs. Association rule analysis identified high-frequency herb combinations such as”Poria-Cassiae Semen-Nelumbinis Folium,” “Cassiae Semen-Crataegi Fructus,” and “Coicis Semen-Poria.” Using network pharmacology, active components and targets of Crataegi Fructus, Cassiae Semen, Nelumbinis Folium, Poria, Astragali Radix, and Coicis Semen were identified. A protein-protein interaction (PPI) network was constructed, and Gene Ontology (GO) enrichment analysis yielded 1,839 entries across molecular function (MF), biological process (BP), and cellular component (CC). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified 186 relevant pathways, primarily enriched in pathways in cancer and the AGE-RAGE signaling pathway. The results demonstrate that MFH-based Chinese patent formulations exert weight-loss effects through multi-component, multi-target, and multi-pathway mechanisms.
No abstract available
No abstract available
No abstract available
No abstract available
Extrusion cooking is an innovative, advanced processing technology widely used in the food and feed industries. With growing concerns over the health attributes of food, the effects of extrusion cooking on the functional characteristics of natural medicinal and edible plants (NMEPs) have attracted increasing attention from researchers. This review, based on recent literature on extrusion cooking, systematically summarizes its impact on the physical properties; functional components, such as total polyphenols, total flavonoids, total polysaccharides, and total saponins; and pharmacological activities, including antioxidant, hypoglycemic, hypolipidemic, and anti-inflammatory effects, of NMEPs. The aim is to provide a scientific basis for the application of extrusion cooking technology in the advanced processing of these resources.
No abstract available
No abstract available
No abstract available
Medicinal and edible plants (MEPs) have attracted increasing interest worldwide due to their natural origin, reliable efficacy, and minimal side effects in recent years. However, the complex and fluctuating levels of inherent chemical constituents and exogenous hazardous contaminants have triggered widespread concerns about their efficacy and safety. Developing analytical methods for both active components and exogenous contaminants concealed in these samples is central to the quality evaluation, in which sample preparation is crucial. This paper systematically reviewed the evolution of standard sample preparation methods, microextraction techniques based on novel solvents and nanomaterials, and innovative integrated techniques from 2019. Accordingly, their merits and weaknesses were discussed by showing fruitful applications in identifying and quantifying active components in these plants. Further, successful applications for analyzing exogenous contaminants were prominently showcased, highlighting the management of pesticides, heavy metals, mycotoxins, and polycyclic aromatic hydrocarbons (PAHs). Finally, forthcoming trends in sample preparation techniques were delineated to illuminate the development and implementation of more advanced sample preparation technologies.
The current status of multi-mycotoxin contamination in edible and medicinal plants demands urgent development of high-throughput analytical methods for mycotoxin detection. In this study, a reliable and sensitive method for the simultaneous analysis of 73 mycotoxins was established and successfully applied to detect mycotoxins in 260 samples of four dual-purpose plants (lotus seed, coix seed, licorice root, and dried tangerine peel). Sample preparation involved optimized QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) extraction combined with liquid–liquid extraction purification, and an enhanced ion pair library was established to reduce matrix interference and improve the method’s universality. Method validation demonstrated recovery rates ranging from 61.6% to 118.6% for all compounds, with relative standard deviations (RSDs) below 15%. The limits of detection (LODs) and quantification (LOQs) ranged from 0.25–12.25 μg/kg and 0.5–25 μg/kg, respectively. Based on the contamination analysis and health risk assessment using Margin of Exposure (MOE) and Hazard Index (HI) methods, we found that multi-mycotoxin contamination is highly prevalent in edible and medicinal plants, with different components being susceptible to invasion by distinct fungal genera. Seed-type plants showed high susceptibility to Aspergillus (53.3%) and Fusarium (22.2%) contamination, with MOE values below 10,000 for aflatoxins indicating potential health risks. Physical state and good storage conditions significantly influenced contamination levels, with fragmented samples showing substantially higher mycotoxin levels. Additionally, mycotoxins with associated biosynthetic metabolic pathways were frequently detected simultaneously in highly contaminated samples. Based on these findings, we recommend implementing strict moisture control during storage, maintaining intact product form where possible, and establishing comprehensive supplier qualification systems. This study provides valuable reference for monitoring mycotoxin contamination in similar plants.
Probiotic fermentation is a novel concoction method of medicinal and edible plants with microbial-specific biotransformation function. Some dipeptides, nucleosides and flavonoids exhibit strong flavor and functional properties and play an...
Abstract Plants provide multiple ecosystem services that can, directly and indirectly, benefit the local community and beyond. This study assessed the diversity of the multiple uses of medicinal plants (MPs) and wild edible plants (WEPs) as well as associated local knowledge in Bako Tibe District, Ethiopia. Based on the recommendation of local authorities, eight key informants were selected out of the general informants (48) at eight sites. Ethnobotanical data were quantitatively analyzed through the use of use values, pairwise comparisons, and reference and direct matrix rankings. In total, 74 species from 61 genera and 36 families were found to have multiple uses. The Fabaceae family had the highest number of species (11), followed by the Moraceae family (eight). Trees were represented by 31 species. Twenty species were used to treat 22 human and livestock ailments. The highest preference ranking was recorded for Ocimum lamiifolium for treating febrile illness. Leaves (55.2%) and fruits (13 species) were the most commonly used parts for MP and WEP species, respectively. The highest use value was recorded for Cordia africana, among the top 10 multipurpose species. The findings showed that the most preferred MP and WEP species need further phytochemical and food nutritional analysis, respectively.
No abstract available
Background The Daur people are one of the 55 minority ethnic groups in China and have lived in Northern China for 300 years. In traditional Daur medicine, medicinal and edible plants (MEPs) are utilised for health benefits and therapeutic purposes; however, related ethnobotanical knowledge is rarely reported, which is disadvantageous for the sustainable development of these MEPs. Methods Semi-structured interviews with 122 informants, six focus group discussions, and a resource survey were conducted in a Daur minority nationality area in Inner Mongolia from 2015 to 2020, and the data statistics were analysed. In this study, we simulated a system dynamics model aimed at understanding the multiple feedback mechanisms involved in the relationships between the cultural influences and socioeconomic factors, sustainable environment, and development of MEPs. Results A total of 52 species of MEPs were identified and relevant ethnobotanical knowledge was assessed using Daur medicinal species data from Inner Mongolia and the Xinjiang region, with the literature and Ewenki ethnic group data used for comparison. The most commonly used medicinal plant species by the Daur were found to be Betula pendula subsp. mandshurica , Artemisia integrifolia , Crataegus pinnatifida , Saposhnikovia divaricata , Artemisia argyi , and Jacobaea cannabifolia . The MEPs most frequently targeted the digestive and rheumatic immunity systems, as well as infectious diseases or parasitic infections and other common diseases and basic health issues. MEP knowledge was primarily limited to older generations; thus, the valuable ethnobotanical knowledge on traditional medicines must be protected from future losses. Conclusions Our findings provide insights for future research aimed at exploiting the rich phytochemical diversity in traditional medicine and promote its use in modern lifestyles. Effective assessment and management of plant resources will lead to their application for the improvement of dietary diversity, nutrition, and health care.
Inflammation has been shown to trigger a wide range of chronic diseases, particularly inflammatory diseases. As a result, the focus of research has been on anti-inflammatory drugs and foods. In recent years, the field of medicinal and edible homology (MEH) has developed rapidly in both medical and food sciences, with 95% of MEH being associated with plants. Phenolic acids are a crucial group of natural bioactive substances found in medicinal and edible homologous plants (MEHPs). Their anti-inflammatory activity is significant as they play a vital role in treating several inflammatory diseases. These compounds possess enormous potential for developing anti-inflammatory drugs and functional foods. However, their development is far from satisfactory due to their diverse structure and intricate anti-inflammatory mechanisms. In this review, we summarize the various types, structures, and distribution of MEHP phenolic acids that have been identified as of 2023. We also analyze their anti-inflammatory activity and molecular mechanisms in inflammatory diseases through NF-κB, MAPK, NLRP3, Nrf2, TLRs, and IL-17 pathways. Additionally, we investigate their impact on regulating the composition of the gut microbiota and immune responses. This analysis lays the groundwork for further exploration of the anti-inflammatory structure-activity relationship of MEHP phenolic acids, aiming to inspire structural optimization and deepen our understanding of their mechanism, and provides valuable insights for future research and development in this field.
No abstract available
Medicinal and edible homologous (MEHs) plants are valuable in medicine and food science as edible plants. Saponins, one of the major chemical components isolated from MEHs plants, have significant antioxidant, anti‐inflammatory, antibacterial, and antiviral biological activities. This paper provides an overview of the basic structure, properties, and bioactivity of saponins, the development of novel delivery systems for their enhanced bioavailability, and their applications in various fields. It also highlights the innovations and challenges of current trends in saponin research and provides a basis for the development of a safe and effective natural active ingredient based on MEHs plants. Through comprehensive analysis, this paper aims to provide a theoretical basis and technical support for further research and application of saponins in food science.
Glucose and lipid metabolism disorders are the core pathological mechanism of a variety of metabolic diseases, and the incidence of related diseases is increasing year by year, which seriously threatens human life and health. Traditional Chinese medicine with medicinal and edible properties refers to Chinese medicinal resources that have both medicinal and edible characteristics. Due to its safety and its health-promoting and medicinal functions, traditional Chinese medicine has received increasing attention in the development of functional health foods. Phenolic acids are important secondary metabolites that are ubiquitous in medicinal and edible homologous plants, and the regulation of glycolipid metabolism is an important activity and plays a key role in many diseases. In this paper, we focus on the alleviation of glycolipid disorders using MEHH phenolic acids, which regulate glucose metabolism and lipid metabolism, improve insulin resistance, inhibit inflammatory responses, alleviate oxidative stress, and regulate intestinal flora; additionally, we summarize the mechanism in order to provide a reference for MEHH phenolic acids in the treatment of glycolipid metabolism diseases.
This study investigates the phylogenetic and geographical distribution of wild food plants (WFPs) across 30 Mediterranean and North African (MENA) regions, focusing on the intersection of evolutionary lineage, ecological adaptation, and cultural utilization. A phylogenetic analysis of 111 genera of WFPs used in traditional diets reveals clusters reflecting shared ancestry, functional adaptations, and ecological resilience. Key regions such as Lebanon and Ikaria stand out as potential centers for the diversity of wild food plant use, suggesting that the Eastern Mediterranean may be a primary origin area, especially for species adapted to semi-arid climates. Major plant families including Lamiaceae, Rosaceae, and Fabaceae form distinct clusters that underscore their common ancestry and adaptability, making them foundational to traditional diets and medicinal applications across various environments. Geographical analysis indicates historical connections, such as those between Malta and Egypt, supporting the hypothesis that ancient trade routes influenced the spread and cultural exchange of wild food plant use across the Mediterranean. The study emphasizes the integration of phylogenetic and ethnobotanical perspectives, shedding light on how biodiversity, ecological adaptation, and cultural practices intersect in these regions. This research demonstrates that WFPs serve as both ecological and cultural assets, crucial for preserving traditional diets and supporting biodiversity conservation amid environmental changes. Integrating evolutionary and cultural knowledge can enrich ecological understanding and contribute to the sustainable use of plant resources in the MENA regions.
Hyperuricemia is another common metabolic disease, which is considered to be closely related to the development of many chronic diseases, in addition to the “three highs.” Currently, although drugs show positive therapeutic effects, they have been shown to produce side effects that can damage the body. There is growing evidence that medicinal and edible plants and their bioactive components have a significant effect on hyperuricemia. In this paper, we review common medicinal and edible plants with uric acid-lowering effects and summarize the uric acid-lowering mechanisms of different bioactive components. Specifically, the bioactive components are divided into five categories: flavonoids, phenolic acids, alkaloids, polysaccharides, and saponins. These active substances exhibit positive uric acid-lowering effects by inhibiting uric acid production, promoting uric acid excretion, and improving inflammation. Overall, this review examines the potential role of medicinal and edible plants and their bioactive components as a means of combating hyperuricemia, with the hope of providing some reference value for the treatment of hyperuricemia.
Sea buckthorn (Hippophae L.), a well-known medicinal and edible plant, is known as the "king of VC". Due to its excellent medicinal and nutritional value, it has been developed into a variety of functional products. Sea buckthorn polysaccharides (SPs), one of the important and representative active components, have attracted the attention of researchers in the fields of health food and medicine because of their potential beneficial effects on human health. Recently, SPs have shown various biological activities in in vitro and in vivo studies, such as anti-obesity, immunomodulatory, anti-tumor, antioxidant, anti-inflammatory, anti-fatigue, and hepatoprotective activities. This review provides a comprehensive and systematic summary of the extraction and purification methods, structural characterization, biological activity, and market trends of SPs to provide a theoretical basis for their therapeutic potential and sanitarian functions. A future scope is needed to further explore the medicinal and nutritional value of SPs and incorporate them in functional food products.
Aging is a complex biological and physiological change that leads to a loss of function in all living organisms. Although the mechanism behind the aging process is still largely unknown, scientific studies have shown that oxidative stress and age-related low autophagy, which are associated with various chronic diseases such as cancer, diabetes, cardiovascular diseases, and neurodegenerative diseases, promote aging. Interestingly, many medicinal plants and their biologically active compounds have the ability to extend lifespan as they can inhibit oxidative stress and promote autophagy. This review evaluates and provides up-to-date information on the anti-aging potential of bioactive compounds in edible medicinal plants. In this study, seventeen (17) biologically active compounds from edible medicinal plants with anti-aging effects were reviewed. In vivo and in vitro studies showed that these biologically active compounds exhibit anti-aging effects via various mechanisms such as the activation of autophagy, increases in antioxidant enzymes, reductions in reactive oxygen species, the inhibition of inflammatory markers, and the downregulation of senescence genes. This study suggests that edible medicinal plants containing these bioactive compounds may promote health and extend lifespan. However, the exact mechanisms, effective doses, clinical trials, and chronic and genotoxic effects of bioactive compounds as anti-aging agents should be further investigated.
No abstract available
No abstract available
Abstract Food therapy of traditional Chinese medicine aims to maintain balanced nutrition through diet. Medical diet therapy, however, is to achieve the balance of Yin and Yang through the combination of nutrition and medicine. Either "food therapy" or "medical diet therapy" aims to keep health, prevent disease, remove illness and slow aging. In recent years, both food therapy and medical diet therapy have been increasingly applied in clinical nutrition therapy. In terms of traditional Chinese food therapy and medical diet therapy, their clinical applications principles are summarized in this article.
Traditional Chinese Medicine (TCM) dietary therapy emphasizes harmony between individual constitution, seasonal changes, and the properties of food, and is widely used for everyday health maintenance. However, most existing dietary apps still focus on calorie counting and static recipes, providing limited personalization and only weak support for understanding TCM principles. In this paper, we propose a personalized TCM dietary therapy interactive system driven by AIGC and present the design and implementation of the mobile app Shi Hao Liao. We first conduct questionnaires and semi-structured interviews, and then apply the Kano model to identify and prioritize user needs across functional, informational, and emotional dimensions. On this basis, we build a three-layer system architecture that integrates a constitution-centered user profile, a constrained AIGC dietary plan generation module, and an interaction layer covering assessment, daily and weekly planning, seasonal recommendations, marketplace integration, and lightweight emotional support. We implement a high-fidelity prototype and conduct a between-subjects user study by comparing the AIGC version with a non-AIGC static baseline (186 participants). Results show that the AIGC-driven design significantly improves perceived personalization and understanding of the underlying TCM rationale while maintaining good usability. This work illustrates how generative models can be embedded into culturally grounded health services in a safe and interpretable way.
Background Traditional Chinese medicine has great advantages in improving symptoms of CHF such as chest tightness, shortness of breath, and fatigue. In addition, some traditional Chinese medicines can be used as both medicine and food, which have good effects on the prevention and treatment of CHF patients at home. Method A comprehensive search across China National Knowledge Infrastructure (CNKI), Wanfang, and Wei Pu (VIP) databases was conducted to retrieve pre-2022 literature related to CHF. After standardization, frequency analysis and Apriori algorithm were used to analyze these data. Result Among 626 effective medical records, Fuling, Huangqi, and Danshen are the most commonly used herbs; The medication for chest tightness is closely related to Tinglizi; The medication for palpitations is closely related to Guizhi, Fuzi, Zhigancao, and Wuweizi; The medication of fatigue and poor appetite is closely related to Huangqi and Baizhu; The medication for lower limb edema is closely related to Fuling and Tinglizi; The medication for coughing is closely related to the use of Tinglizi, Wuweizi, Kuxingren, and Sangbaipi; Insomnia is closely related to Suanzaoren and Dazao. Conclusion The components in traditional Chinese medicine that have anti heart failure effects and reliable evidence can be potential candidates for drug discovery, while dietary therapeutic herbs such as Fuling, Huangqi, Danshen, and Zhigancao can be developed as health products.
This study explores the potential mechanisms of Traditional Chinese Medicine (TCM) dietary therapy in intervening with recurrent urinary tract infections (rUTI) in women, based on the TCM theory of “food as medicine” and metabolomics technology. Starting from the core pathogenesis of “spleen-kidney damp-heat, stasis, and toxic complex,” this research analyzes the properties, flavors, and meridian tropism of spleen-strengthening and kidney-tonifying foods such as Chinese yam and Poria, as well as heat-clearing and dampness-reducing foods like Amaranth and mung beans. It combines the principles of flavor balance and meridian targeting in dietary prescriptions to elucidate their scientific connotations in regulating energy metabolism, improving oxidative stress status, controlling the gut-urinary axis microbiota, and estrogen-related metabolism, thereby repairing the urothelial barrier and enhancing mucosal immunity. The study reveals that the dietary therapy with the same origin of food and medicine acts through multi-component and multi-target synergistic effects to reshape the “host-microbiota-metabolism” balance, providing a theoretical basis for the integration of Chinese and Western medicine in the prevention and treatment of female rUTI.
No abstract available
No abstract available
Depression has become the leading cause of disability worldwide. Conventional serotonergic antidepressants fail to meet anticipated outcomes and increase the risk of drug dependency and side effects. Consequently, the significance of diet and nutrition in the prevention and management of depression and anxiety has increasingly received attention. Many years of clinical practice have shown that edible traditional Chinese medicines can relieve depression through their anti‐inflammatory properties, potentially acting as a nutritional remedy for depression with a higher acceptance rate and safety. In this review, we elucidated how deficiency tonic medicines in edible traditional Chinese medicines and their ingredients modulate the immune response and gut microbiota to alleviate depression. This article can offer new insights into the antidepressant effect of daily dietary treatments.
In-depth research on the mechanism of food nutrition and bioactivity has always been a shortcoming. The main function of the food itself is to meet the nutritional needs of the human body, not the therapeutic effect. Therefore, its relatively modest biological activity makes it difficult to study in general pharmacological models. With the popularity of functional foods and the concept of dietary therapy, the development of information and multi-omics technology in food research, the mechanism research of food is also moving towards a more microscopic future. Network pharmacology has accumulated nearly 20 years of experience in the research of traditional Chinese medicine (TCM), among which there is no lack of TCMs for both medicinal and edible purposes. Based on the similarity in the "multi-component-multi-target" properties of food and TCM, we think that network pharmacology is applicable to the study of the complex mechanism of food. In this review, we review the development of network pharmacology, summarize its application in "medicine and food homology", and proposal the methodology based on food characteristics for the first time, thereby demonstrating its feasibility in food research. This article is protected by copyright. All rights reserved.
Purpose: Extract key factors to determining the acceptability of diet therapy based on syndrome differentiation of Traditional Chinese Medicine for middle-aged and elderly people and propose some suggestions to improve their acceptance of it. Method: Thirteen main influencing factors are selected from literature survey and interviews. Semi-structured interview are conducted with Decision-Making Trial and Evaluation Laboratory questionnaires to evaluate factors’ interrelationship. Results: The understandability and the memorability of medicinal food’s knowledge, the type of medicinal food and the popularity of medicinal food’s knowledge are key influencing factors. Suggestions: Pre-research of people’s taste preferences is important and necessary; the identity of propagandist and the source of propaganda content should be transparent and the organization of publicity activities should be normalized; concise and multi-sensory propagation mode should be adopted; “Medicinal Virtue Association” can be used to reduce the difficulty of memorizing knowledge.
As reperfusion therapy becomes more common, cerebral ischemia-reperfusion (I/R) injury has emerged as a notable factor affecting the outcome of ischemic stroke. The intricate pathological mechanisms involved include oxidative stress, neuroinflammation, and various forms of cell death, characterized by interactions between multiple signaling pathways. Natural products, such as traditional Chinese medicines (TCMs), offer multi-targeted intervention effects through their diverse natural active compounds and integrate pharmacological and nutritional functions into 1 entity (Food and Medicine Homology), supporting their long-term use to prevent cerebral I/R injury. It was found that TCMs, such as Gastrodia elata Blume and Lycium barbarum L., potentially exert synergistic effects on redox imbalance, inflammation, apoptosis, and autophagy by concurrently modulating various pathways, including Nrf2/ARE, NF-κB, PI3K/Akt/mTOR, Bcl-2/Bax, and PARP-1. The prophylactic administration of TCMs may represent a novel approach for mitigating cerebral I/R injury. To advance the application of TCMs from the laboratory to clinical practice, it is essential to conduct clinical research to confirm their effectiveness and safety in preventing cerebral I/R injury.
No abstract available
No abstract available
Abstract Rehmannia glutinosa Libosch, Achyranthes bidentata Bl. (A. bidentata), Dioscorea opposita Thunb, and Chrysanthemum morifolium Ramat (C. morifolium) are known as the ‘Four Huaiqing Chinese Medicine’ in China, which are used as materials for functional foods. In this paper, the constituents of Four Huaiqing Chinese Medicine were identified by UPLC-Q-TOF-MS/MS, and flavones and aromatic compounds are mainly responsible for these herbs. Moreover, C. morifolium exhibited the most significant effect in cobalt chloride-induced HUVECs injury, which could decrease cell apoptosis and the overproduction of ROS, lactic dehydrogenase (LD) and pyruvic acid, and increase the migration capacity of cells. Meanwhile, A. bidentata exhibited the most significant effect in isoproterenol-induced H9C2 cell injury, which could decrease the levels of ROS overproduction, BNP, NO, LD and pyruvic acid. Western blot revealed that C. morifolium and A. bidentata also could decrease the levels of bax/bcl-2 ratio, cleaved caspase-3, cytochrome c, HIF-1ɑ, GLUT1, HKII and PFKFB3, respectively. GRAPHIC ABSTRACT
Neurological disorders pose significant global public health challenges, with a rising prevalence and complex pathophysiological mechanisms that impose substantial social and economic burdens. Traditional Chinese Medicine (TCM), with its holistic approach and multi-target effects, has gained increasing attention in the treatment of neurological diseases. This review explores bioactive compounds derived from Chinese herbal plants, focusing on their mechanisms of action, underlying pathways, and potential applications in functional food development. The review highlights the neuroprotective properties of flavonoids, alkaloids, polysaccharides, and polyphenols found in key TCM herbs such as Scutellaria baicalensis, Salvia miltiorrhiza, Ligusticum chuanxiong, and Gastrodia elata. These compounds have demonstrated significant anti-inflammatory, antioxidant, and neurogenic effects, making them promising candidates for the prevention and treatment of neurological conditions, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and depression. Furthermore, the synergistic effects of TCM formulations targeting multiple signaling pathways offer advantages over single-target therapies, especially in combating neurodegenerative diseases. The review also discusses the challenges and future directions for integrating these bioactive compounds into functional foods and dietary supplements, aiming to improve neurological health and enhance clinical outcomes. Ultimately, this work aims to provide valuable insights into the potential of TCM-based interventions for promoting neurological well-being and addressing the global burden of neurological disorders.
No abstract available
FMs (Food-borne melanoidins) are brown high molecular weight polymers formed by the Mailiard reaction between carbohydrates and nitrogen-containing compounds during the processing of food or Traditional Chinese Medicine (TCM), and are widely found in food-borne products such as TCM concoctions, bakery, brewing, soy sauce, ferment and other food-borne products. FMs not only have a variety of biological activities, such as antioxidant, antibacterial, immunomodulation, regulation of intestinal flora, etc., and can change the color, aroma and taste of food. The diversity of its components has become a research hotspot at home and abroad in recent years, with a wide range of application prospects. Therefore, this paper summarizes the existing information on FMs at home and abroad, mainly describes their preparation process, physicochemical properties, structural characteristics and functional activity research progress. Typical FMs, such as coffee, biscuits, wine and soy sauce in daily food, and Polygonatum, Perilla oil, Black ginseng, and Red jujube in T, were highlighted. Summarising the current status of research between the chemistry and pharmacodynamics of relevant FMs and presenting challenges and future recommendations for melanoidin research. In future research on FMs, one should pay more attention to basic research, especially isolation and purification and generation mechanisms, to further demonstrate the biological activity of FMs in vivo and in clinical trials. Thus, the potential value of its existence is deeply exploited to meet the needs of technology, production and health.
Euryale ferox Salisb. (prickly water lily) is the only extent of the genus Euryale that has been widely distributed in China, India, Korea, and Japan. The seeds of E. ferox (EFS) have been categorized as superior food for 2000 years in China, based on their abundant nutrients including polysaccharides, polyphenols, sesquineolignans, tocopherols, cyclic dipeptides, glucosylsterols, cerebrosides, and triterpenoids. These constituents exert multiple pharmacological effects, such as antioxidant, hypoglycemic, cardioprotective, antibacterial, anticancer, antidepression, and hepatoprotective properties. There are very few summarized reports on E. ferox, albeit with its high nutritional value and beneficial activities. Therefore, we collected the reported literature (since 1980), medical classics, database, and pharmacopeia of E. ferox, and summarized the botanical classification, traditional uses, phytochemicals, and pharmacological effects of E. ferox, which will provide new insights for further research and development of EFS-derived functional products.
Introduction Fatigue has attracted broad attention in recent years due to its high morbidity rates. The use of functional foods to relieve fatigue-associated symptoms is becoming increasingly popular and has achieved relatively good results. In this study, network pharmacology and molecular docking strategies were used to establish the material basis and mechanisms of Chinese herbal compounds in fatigue treatment. According to traditional medicine theories and relevant guidance documents published by the Chinese Ministry of Health, four herbal medicines, including Eucommia ulmoides Oliver bark, Eucommia ulmoides Oliver male flower, Panax notoginseng, and Syzygium aromaticum (EEPS), were selected to constitute the anti-fatigue herbal compound that may be suitable as functional food ingredients. Methods The major active ingredients in EEPS were identified via comprehensive literature search and Traditional Chinese Medicine Systems Pharmacology database search. Corresponding targets for these ingredients were predicted using SwissTargetPrediction. The network was constructed using Cytoscape 3.9.1 to obtain key ingredients. Prediction of absorption, distribution, metabolism, excretion and toxicity properties was performed using the ADMETIab 2.0 database. The anti-fatigue targets were retrieved from GeneCards v5.13, OMIM, TTD and DisGeNET 7.0 databases. Then, the potential targets of EEPS in fatigue treatment were screened through a Venn diagram. A protein–protein interaction (PPI) network of these overlapping targets was constructed, and the hub targets in the network selected through topological screening. Gene Ontology and KEGG pathway enrichment analyses were performed using the DAVID database and the bioinformatics online platform. Finally, AutoDock tools were used to verify the binding capacity between the key active ingredients and the core targets. Results and Discussion This study identified the active ingredients and potential molecular mechanisms of EEPS in fatigue treatment, which will provide a foundation for future research on applications of herbal medicines in the functional food industry.
Licorice-derived prenylated flavonoids and triterpenoids undergo intricate biosynthetic pathways, conferring distinctive structural features and bioactive properties. These compounds are integral to traditional Chinese medicine, serving as functional food ingredients, and having broad applications in various industries. The up to date reports on prenylated flavonoids and triterpenoids found in licorice are reviewed in this paper. Their structural characteristics and fragmentation profiles in mass spectrometry are described. These compounds possess multiple biological activities, including antioxidant, anti-inflammatory, antibacterial, antiviral, and antitumor activities. Additionally, techniques for obtaining these bioactive constituents are introduced, ranging from natural plant extraction to biosynthetic approaches. The discussion culminates with an exploration of their applications in the food and cosmeceuticals industries. The compilation and analysis of these data establish a scientific foundation for the development of nutraceuticals and health-promoting products enriched with licorice prenylated flavonoids and triterpenoids.
Polysaccharides, a class of complex macromolecules, are distinguished by their diverse biological functions and essential role in functional foods. The distinctive biological activities of polysaccharides from medicine and food homology materials (MFPs), including immunomodulation, carbohydrate metabolism regulation, and lipid metabolism regulation properties, have attracted considerable scientific attention. The relationship between polysaccharides and gut microbiota is fundamental to human health, as polysaccharides demonstrate efficacy in ameliorating various conditions-from inflammatory bowel disease (IBD) to obesity and diabetes-through their influence on intestinal flora composition and diversity. Although polysaccharide research and applications show promise, significant challenges persist, particularly regarding extraction and purification methodologies, and the complete understanding of their biological mechanisms. Future investigations should prioritize understanding the correlation between polysaccharide structure and function, advancing large-scale production and application technologies, and establishing productive interdisciplinary collaborations. MFPs demonstrate significant potential for advancing sustainable development and human health, building upon current research findings. This paper presents a comprehensive review of global developments in the extraction, purification, structural characterization, biological activities, and applications of MFPs, emphasizing opportunities for scientific and technological innovations in specialized dietary food development.
No abstract available
Dandelion is a wild herbaceous plant commonly consumed in the daily diet of Western countries. It contains large amounts of nutrients including minerals, iron, calcium, sodium, magnesium, and vitamins A, B, C, E, and K. It is also a traditional Chinese medicine with a wide range of pharmacological activities including antimicrobial. In traditional Chinese medicine, dandelion is “isogenic of medicine and food”, which may be functional as food and medicine. “Chinese herbal salad” is a usual choice for the Chinese; but, it is difficult to classify its quality and quantity. The quality relies on the place of origin or method of cultivation, and the quantity depends on the amount of dandelion used in making Chinese herbal salad for a specific function, such as antibacterial properties. Therefore, the present work designed a functional food (Chinese herbal salad) using dandelion as the ingredient, and compared different cultivation methods (soil or hydroponic) in terms of their antibacterial properties. A questionnaire survey was also conducted on the dandelion salad to verify its acceptance and suitability for use in salad recipes. This would develop a more diverse and innovative dandelion food available to the public, and promote the use of this herbal plant as a health and nutritional supplement in the daily diet.
Metabolic syndrome (MetS) is a common disorder involving a cluster of metabolic abnormalities, such as abdominal obesity, hypertension, dyslipidemia, insulin resistance, and atherogenic profile. MetS is characterized by an increase in oxidative stress and a chronic proinflammatory state, which are directly related to the development and progression of this pathology. It has been seen how a healthy lifestyle and good dietary practices are key to improving the different metabolic parameters and, therefore, play a fundamental role in reducing the risk of developing diabetes. The present review focuses on the research evidence related to the therapeutic properties of Lycium barbarum L. in MetS gathered in the last years. Several preclinical studies suggest that L. barbarum extracts are a good dietary supplement for the prevention of cardiovascular diseases in people with MetS. This compound has been used for years in traditional Chinese medicine for the treatment of atrophic gastritis, problems related to the lungs, kidneys, and liver, and as a supplement for eye health. In addition, different in vitro and in vivo studies have been carried out that support the properties attributed to metabolites derived from L. barbarum, such as polysaccharides that have been shown diverse biological activities. In conclusion, L. barbarum extracts have multiple benefits to increase general well‐being and immune function. However, there are a limited number of studies related to effect of L. barbarum in MetS, but they demonstrated effectiveness in the treatment of obesity, diabetes mellitus type 2, and prevention of diabetes mellitus type 2 complication.
No abstract available
No abstract available
Bioactive peptides derived from traditional Chinese medicine and traditional Chinese food: A review.
No abstract available
Many traditional Chinese herbs contain pyrrolizidine alkaloids (PAs), which have been reported to be toxic to livestock and humans. However, the lack of PAs standards makes it difficult to effectively conduct a risk assessment in the varied components of traditional Chinese medicine. It is necessary to propose a suitable strategy to obtain the representative occurrence data of PAs in complex systems. A comprehensive approach for annotating the structures, concentration, and mutagenicity of PAs in three Chinese herbs has been proposed in this article. First, feature-based molecular networking (FBMN) combined with network annotation propagation (NAP) on the Global Natural Products Social Molecular Networking web platform speeds up the process of annotating PAs found in Chinese herbs. Second, a semi-quantitative prediction model based on the quantitative structures and ionization intensity relationship (QSIIR) is used to forecast the amounts of PAs in complex substrates. Finally, the T.E.S.T. was used to provide predictions regarding the mutagenicity of annotated PAs. The goal of this study was to develop a strategy for combining the results of several computer models for PA screening to conduct a comprehensive analysis of PAs, which is a crucial step in risk assessment of unknown PAs in traditional Chinese herbal preparations.
Poria cocos is a medicinal fungus that has been used for millennia in traditional Chinese medicine as a functional food and for the treatment of diabetes and other diseases. We and other groups have demonstrated that P. cocos and its active compounds can effectively control blood glucose and diabetic ulcers in animals and humans with diabetes. This review consolidates information on the phytochemistry, function, and mechanisms of P. cocos, providing an updated reference. The novelty and key findings regarding P. cocos have been critically evaluated, including its phytochemistry, pharmacology, and clinical potential, as well as those of its active compounds at the molecular, cellular, animal, and human levels. A systematic literature search of reports from 2002 to 2025 was conducted using the public databases and keywords. Publication selection was based on a well‐established retrieval protocol. The research findings reviewed emphasize the functions and mechanisms of terpenes/terpenoids and polysaccharides in P. cocos that can mitigate diabetes and its foot ulcers in patients. In brief, P. cocos improves the clinical efficacy of oral anti‐diabetic agents and reduces their side effects. Mechanistically, P. cocos terpenes and polysaccharides mitigate diabetes and diabetic ulcers by reducing peripheral insulin resistance via the PI3K/AKT pathway. In summary, this review provides fundamental information about this fungus and suggests directions for further basic research and application.
Lion's Mane mushroom (Hericium erinaceus) holds a significant place in traditional Chinese medicine (TCM), valued for centuries for benefiting various internal organs and overall well-being. It is also celebrated as a culinary delicacy in East Asia, prized for its fleshy, meat-like texture and mild, seafood-like flavor. High concentrations of glutamic and aspartic acids generate a pronounced umami taste, enhancing its culinary appeal and supporting its use as a natural flavor enhancer. Nutritionally, it provides dietary fiber, essential minerals, and high protein content, notably in the mycelial biomass (up to 42.5% dry weight), making it especially suitable as a protein source in meat alternative applications. The mushroom's therapeutic potential is rooted in its novel bioactive constituents. Hericenones (in fruiting bodies) and erinacines (in mycelia) are diterpenoids that stimulate nerve growth factor (NGF) synthesis, supporting neuronal function. Furthermore, immunomodulatory β-glucans, antioxidant phenolic compounds, and ergothioneine contribute to its overall health benefits. However, these functional properties are predominantly supported by in vitro and animal studies. Despite growing interest in its medicinal properties, integrated evaluations of the nutritional composition, bioactive profile, and technological potential of H. erinaceus for modern food applications remain limited. By leveraging both its sensory attributes and scientifically validated functional value, H. erinaceus can be incorporated into beverages, staple foods, and meat substitutes. This comprehensive review examines its dual role as a medicinal and culinary mushroom, to hopefully enhance understanding of the mushroom and inspire its future applications in food technology.
ETHNOPHARMACOLOGICAL RELEVANCE Medicinal and edible herbs (MEHs), including ginger (Zingiber officinale), goji berries (Lycium barbarum), and hawthorn (Crataegus pinnatifida), serve dual roles as both dietary components and therapeutic agents. Their pharmacological activities are primarily attributed to natural bioactive compounds, such as polysaccharides polyphenols, flavonoids, and saponins. These constituents exhibit multifunctional properties, including antioxidant, anti-inflammatory, and immunomodulatory effects. AIMS OF THE REVIEW This study identifies 61 herbs that exhibit protective effects against Alcoholic liver disease (ALD). These herbs are classified according to their medicinal parts and reviewed with regard to their source, function, active ingredients, signaling pathways, and mechanisms of action. MATERIALS AND METHODS This study screened 106 MEHs officially recognized in China as of 2025 through a comprehensive search of both domestic and international databases (CNKI, Wanfang Data Knowledge Service Platform, ACS database, Springer database, Elsevier ScienceDirect, PubMed). RESULTS In this review, we summarize the mechanisms and pharmacological activities of MEHs, thereby providing insights for the development of drugs, functional foods, and health products aimed at the prevention and treatment of ALD. CONCLUSIONS Current clinical management of ALD primarily depends on monotherapeutic approaches utilizing single active components with poorly defined molecular targets. This strategy carries risks of off-target effects and dose-limiting toxicities, thereby constraining its broader therapeutic utility. Compared to pure drugs, these herbs generally have fewer adverse effects, are suitable for prolonged use, and are appropriate for a wide range of people, especially those with weaker constitutions.
Germination is a developmental stage in which plants accumulate higher levels of bioactive metabolites. However, this potential remains largely unexplored in medicinal herbs and therapeutic applications. Sprouting represents a brief yet metabolically dynamic phase in plant development, during which dormant seeds initiate enzymatic activation and begin synthesizing a range of bioactive compounds. Compared to dry seeds or mature plants, sprouts often contain higher levels of phenolics, flavonoids, vitamins, and other secondary metabolites, enhancing their nutritional and pharmacological value. While edible sprouts from food crops have been extensively studied, sprouts derived from medicinal plants remain largely overlooked. This is surprising given their natural richness in pharmacologically relevant phytochemicals. This perspective draws primarily on original experimental studies that investigated phytochemical and physiological changes during sprouting of medicinal plants. These studies were identified through searches in scientific databases using keywords related to medicinal plants, sprouts, and bioactive compounds. We summarize existing studies on species such as Trigonella foenum-graecum, Nigella sativa, Silybum marianum, Arctium lappa, Trifolium pratense, and Glycyrrhiza uralensis, and identify other promising candidates with high germination potential but uncharacterized phytochemical profiles at the sprout stage. Environmental variables, such as light quality, seed priming, or nutrient supplementation, can further modulate phytochemical composition during germination. We also discuss practical limitations, including low biomass yield, microbial safety concerns, and lack of standardized protocols. Overall, sprouts offer a responsive, scalable, and experimentally tractable model for exploring and optimizing phytochemical expression in medicinal plants. We propose that this early developmental window offers overlooked opportunities for phytopharmacology, functional foods, and natural product discovery.
No abstract available
Luteolin (Lut) is an important plant-derived flavonoid that is widely distributed in edible herbs and vegetables. Studies on animal and human models have shown that Lut exhibits various pharmacological properties, viz. anti-inflammatory, anti-cancer, anti-oxidant, anti-apoptotic, and neurotrophic actions. The ongoing pandemic coronavirus disease-2019 (COVID-19), is a disease of the respiratory tract that consists of mild to severe symptoms of pneumonia including fever, muscle aches, sore throat, coughing, and shortness of breath. It is of particular concern in older people and patients with chronic diseases having cardiovascular and blood clotting issues or who have compromised immune. This situation prompted us to evaluate the bioactive compounds which are being used to prevent respiratory-related illness. Lut is one such compound which is used as an anti-inflammatory agent. Several studies have explained the protective nature of Lut by inhibiting virus entry and fusion with human receptors in old SARS-CoV that had emerged in 2003. Thus, regular consumption of foods having adequate amount of Lut in our diet may be helpful in inhibiting the SARS-CoV-2 infection as well and may prevent the consequent symptoms in COVID-19 patients. In present work, we have carried out the molecular docking studies of Lut with six different SARS-CoV-2 encoded key proteins. The FDA-approved drug remdesivir was also evaluated as control to compare the results. Lut showed excellent inhibitory action against papain-like proteinase, a main protease of SARS-CoV-2. Lut was also many times more active than remdesivir. Therefore, the foods which have Lut in adequate amount might be explored further for potential use against COVID-19
Edible flowers are becoming a popular addition to diets. As science has progressed, it has been proven that in addition to their aesthetic value, they possess pharmacological effects and health-promoting properties. Several edible flowers are used in medicine, and the available literature data indicate their broad biological activity. This review focuses on pharmacological knowledge about the neuroactive, antioxidant, and anti-inflammatory potential of 15 traditionally used edible flowers. It also describes their traditionally uses and summarizes research findings on their chemical composition.
INTRODUCTION This review aims to explore the therapeutic potential and safety of herbal biactive compounds in the treatment of various liver disorders. As the liver plays a critical role in digestion, detoxification, energy storage, and protein synthesis, any impairment in its function can lead to significant health complications. The study aims to identify effective herbal agents that may support liver health. METHODS A comprehensive literature search was conducted using scientific databases and platforms including Web of Science, Scopus, PubMed, HINARI, ScienceDirect, and Google Scholar. The review includes studies that investigate the hepatoprotective potential of herbal bioactives, while research related to hepatic cancers was excluded to maintain a focus on non-malignant liver disorders. RESULTS The review identifies several medicinal plants and their active constituents that exhibit hepatoprotective properties. These bioactives function through various pharmacological mechanisms at the molecular level. Common liver conditions addressed include fatty liver, hepatitis, fibrosis, steatosis, and cirrhosis. The reviewed compounds demonstrate antioxidant, anti-inflammatory, and antifibrotic activities, supporting their role in liver disease management. DISCUSSION The findings support growing evidence that herbal bioactives can modulate key molecular pathways involved in liver disorders. These results align with existing studies highlighting the benefits of plant-based treatments. However, the limitations include a lack of clinical trial data, poor bioavailability of some compounds, and the need for standardized formulations. Further research is necessary to validate these results in human populations. CONCLUSION Herbal bioactives such as flavonoids, polyphenols, alkaloids, glycosides, saponins, vitamins, and essential oils show promising hepatoprotective effects. This review emphasizes the importance of understanding their precise molecular mechanisms and ADME (absorption, distribution, metabolism, and excretion) profiles. These insights are crucial for developing safe, effective, and standardized herbal therapies for liver disease management.
Thai edible indigenous vegetables are used as traditional food and folklore medicines. This review aims to integrate consumption culture and functional health impact of eight edible plants, that are, Gnetum gnemon var. tenerum, Gymnema inodorum (Lour) Decne, Albizia lebbeck (L.) Benth, Melientha suavis Pierre, Sauropus androgynus, Glochidion wallichianum, Piper sarmentosum Roxb, and Basella alba L., which are commonly consumed by local Thai people. Reviews of all eight mentioned plants demonstrated essential pharmacological activity, including antioxidant activity, and health functions, such as antidiabetic, anti-obesity, antihypertensive, antimicrobial, anti-cancer, and anti-inflammatory usage; they also help prevent neurotransmitters from degrading. However, comprehensive animal tests and clinical trials are needed to further clarify the results to increase utilization and safety as well as commercialization of these plants.
This article explores the therapeutic potential of bioactive compounds found in spices and herbs, focusing on preclinical evidence and their medicinal applications.Spices and herbs have been utilized for centuries in traditional medicine due to their diverse range of bioactive compounds, which exhibit a variety of health-promoting properties.The review synthesizes current research on the pharmacological effects of these compounds, including their anti-inflammatory, antioxidant, antimicrobial and anticancer activities.By examining preclinical studies, the article highlights how these bioactive compounds can modulate biological pathways and offer potential therapeutic benefits.The discussion also covers the mechanisms through which these compounds exert their effects and the implications for developing novel treatments.The evidence underscores the importance of integrating spices and herbs into modern therapeutic practices and encourages further research to fully understand their medicinal value.
Capsella bursa-pastoris (L.) Medik. (shepherd’s purse) is a medicinal plant recently introduced to European Pharmacopoeia. The main active compounds responsible for the activity profile of the raw material are flavonoids, phenolic acids, amino acids, phytosterols, vitamins and bioelements. This species is known for its properties supporting the functioning of the digestive system and antihemorrhagic properties in the ethnomedicine of Far Eastern countries. Modern research confirms these directions of activity. Additionally, the latest studies prove the anti-inflammatory, antioxidant, antibacterial, antifungal, acetylcholinesterase and anticancer properties and supportive action in the treatment of gynecological diseases. Shepherd’s purse herb also has a strong position as an edible plant due to the growing interest in this plant as “healthy food”. The protective, softening, antibacterial and antioxidant properties of sprout and herb extracts are useful in the production of modern cosmetics. Moreover, C. bursa-pastoris is valuable thanks to phytoremediation properties and the numerous practical uses in biotechnology for the creation of new resistant varieties of crop plants from the Brassicaceae family.
A functional Huangjiu-based liqueur (called by Lujiu in China), a type of Chinese rice wine, was developed by incorporating Chinese gall leaven, as a medicinal–edible homologous ingredient, into the fermentation process to enhance its bioactivity. The physicochemical properties and enzymatic activities were investigated and found that supplementation with 2% (v/v) Chinese gall leaven optimized fermentation efficiency and substrate utilization. The co-fermentation significantly elevated the concentrations of bioactive compounds and improved antioxidant capacity, particularly free radical scavenging activity. Compared to traditional Chinese rice wine, the supplemented variant exhibited markedly higher levels of malic acid and phenolic acids. GC-MS analysis identified 85 and 84 volatile flavor compounds in the two supplemented variants, respectively, exceeding the 70 compounds detected in traditional Huangjiu. GC-IMS further revealed significant enrichment of key alcohols (e.g., 3-methyl-1-butanol, 2-methyl-1-propanol) and aldehydes (e.g., propanal, acetaldehyde) in the supplemented group. Microbial community analysis indicated distinct shifts, with increased relative abundances of Pediococcus, Lactiplantibacillus, Aspergillus, and Saccharomyces in the Chinese gall leaven-supplemented fermentation. These results suggest that the native microflora and enzymatic systems of Chinese gall leaven could enhance microbial metabolism and fermentation efficiency, thus contributing to the unique characteristics of rice wine and providing a novel strategy for functional Huangjiu-based liqueur production.
Owing to their nutritional, culinary, and nutraceutical, mushrooms are worldwide consumed and appreciated. Moreover, many of these mushrooms are also known as medicinal mushrooms since they possess several pharmacological properties attributable to a huge number of bioactive compounds derived from their sporophores. Several studies are available in the literature about in vitro and in vivo mechanisms of actions of such bioactive compounds. Most of these surveys are focused on macrofungi belonging to the genera Pleurotus, Ganoderma, or specific taxa such as Agaricus bisporus, Agaricus blazei, Boletus eduliInonotus obliquus, Hericium erinaceus, Lentinula edodes, and Grifola frondose. On the other hand, there is a lack of information on the under investigated ecological group of freshwater fungi. These fungi play a very important role in freshwater environments and some of them, belonging to Basidiomycota, are also edible and largely consumed. In this review we collected information about the medicinal properties of freshwater macro- and micromycetes. Among them, macrofungi, such as Amanita vaginata, Armillaria mellea, Armillaria tabescens, Astraeus hygrometricus, Auricularia auricula-judae, Bjerkandera adusta, Bovista nigrescens, Calocybe gambosa, Candolleomyces candolleanus, Collybia dryophila, Coprinus comatus, Cyclocybe cylindracea, Hypsizygus ulmarius, Inonotus hispidus, Lactarius controversus, Lentinus tigrinus, and Schizophyllum commune, observed in riparian habitat, and microfungi, such as Penicillium aculeatum, P. chrysogenum, and Fusarium incarnatum, isolated from aquatic plants, have been reported to have antimicrobial, anticancer, anti-inflammatory, antioxidant, antidiabetic, immunomoludatory, hypoglycaemic, and other pharmaceutical activities. Such fungal species are noteworthy since they represent an important quote of biodiversity to preserve their fundamental ecological role and a possible solution for different health problems for humans and animal farms.
MicroRNAs (miRNAs) have emerged as critical regulators in the pathogenesis of diabetes mellitus (DM) and its associated complications via orchestrating key cellular processes. Natural bioactive components such as flavonoids, polysaccharides, saponins, alkaloids, terpenoids, as well as anthraquinones derived from berries, herbs, vegetables, and fishes have been extensively demonstrated to treat or prevent DM and related complications through targeting miRNAs‐mediated signaling pathways. Mechanistically, these compounds treat/prevent DM and its complications principally by modulating processes including glucose homeostasis, inflammatory response, oxidative stress, apoptosis, and autophagy, neovascularization, and fibrosis. This paper reviews the roles of miRNAs in DM and relevant complications and focuses on the potential molecular mechanisms of natural bioactive compounds in the treatment of DM and its complications by targeting miRNAs, with the aim of facilitating the development of miRNA‐targeted edible natural products as functional foods as well as their clinical application in the treatment of DM and related complications.
Luohan Guo (Siraitia grosvenorii) is a traditional food homologous fruit in China, which is famous owing to its rich natural antioxidant secondary metabolites. However, the impacts of ripening stages and edible parts on high-resolution metabolic profiles of Luohan Guo are poorly understood till now, greatly limiting its comprehensive utilization. In this study, an LC-QTOF/MS-based non-targeted metabolomics approach was carried out to reveal the dynamic accumulation of metabolites in the peel and pulp of Luohan Guo across seven growth stages, and further revelation their potential pharmacological activities and mechanisms in the treatment of oxidative stress using the network pharmacology strategy. The results demonstrated that the majority of bioactive ingredients showed great accumulation at the immature stages in both peels and pulps, and the levels of flavonoid glycosides and terpenoid saponins gradually declined as ripening progressed. Notably, the comparative analysis between the full-blown peel and pulp indicated that the peel had higher concentrations of flavonoids, phenols, and alkaloids, whereas terpenoids and amino acids were the significantly enriched bioactive ingredients in the pulp. In addition, network pharmacology analysis screened 28 key pharmacological compounds in Luohan Guo, which primarily acted on 65 core targets to alleviate diseases induced by oxidative damage and predominantly accumulated in the peels collected between the 10th and 20th days, endowing immature peel with the best antioxidant properties. These findings offer valuabley theoretical insights for understanding the secondary metabolite accumulation in different ripening stages and edible parts of Luohan Guo and improving its comprehensive utilization rate.
ABSTRACT Ganoderma lucidum, a distinguished traditional medicinal herb, has long been recognized for its purported benefits in promoting physical well‐being, enhancing stamina, and boosting vitality. However, the mechanistic underpinnings of its antitumor activities and other therapeutic effects remain incompletely understood. Historically, the activation of host immune responses was widely regarded as the sole mechanism by which G. lucidum exerts its anticancer effects. Recent advancements, however, have revealed that its antitumor mechanisms extend beyond immune modulation to include induction of cell differentiation, inhibition of angiogenesis, and other molecular pathways. Despite its established status as a functional food and potential therapeutic agent, G. lucidum remains an underexplored resource in modern nutraceutical and pharmaceutical research. Notably, few bioactive compounds derived from this mushroom have been clinically validated as superior to existing therapies for disease treatment. This review systematically summarizes the primary bioactive components of G. lucidum, including polysaccharides, triterpenoids, peptides/proteins, and sterols and discusses their multifaceted health benefits. Additionally, critical insights into optimizing its industrial applications and evaluating its safety profile are highlighted, emphasizing the need for further research to translate its traditional uses into evidence‐based interventions.
Simple Summary Auricularia mushrooms are a popular edible fungus with a long history of cultivation and are valued for their potential health benefits. However, there is still a lack of comprehensive understanding regarding their full potential. This review aims to bridge this knowledge gap by systematically compiling and analyzing existing research on these mushrooms. We explore their biological characteristics, cultivation methods, and the various beneficial compounds they contain, such as polysaccharides and melanin, which are known to help with blood sugar control, immune support, and antioxidant activity. The study also highlights their expanding applications beyond food, including uses in drug delivery systems and eco-friendly materials. We identify key challenges, particularly the need for more sustainable cultivation practices. By summarizing the current state of knowledge and future prospects, this work provides a valuable resource for researchers, farmers, and industries, ultimately promoting the broader and more sustainable use of Auricularia mushrooms for improving human health and advancing biotechnology. Abstract The genus Auricularia, and specifically the species A. auricula, is a globally significant edible fungus with a long history of cultivation and notable nutritional and medicinal properties. This review systematically examines the taxonomic classification, morphological and physiological characteristics, and bioactive components (such as polysaccharides, melanin, proteins and polyphenols) of A. auricula, as well as their pharmacological effects and industrial applications. Recent molecular biological advances have clarified taxonomic uncertainties, including the reclassification of ‘heimuer’ as A. cornea, and emphasized the species’ genetic diversity. A. auricula thrives in temperate and subtropical regions, with cultivation techniques evolving from traditional wood log inoculation to modern substrate-based methods. However, sustainability challenges persist, including reliance on virgin wood substrates and the need for improved spent substrate management. The fungus exhibits remarkable nutritional properties, with polysaccharides (up to 66.1% of dry weight) demonstrating hypoglycemic, antitumor, immunomodulatory, and antioxidant activities. Melanin and proteins further contribute to hepatoprotection, antimicrobial effects, and metabolic regulation. Industrial applications of Auricularia species extend beyond food into pharmaceuticals and functional materials. Polysaccharides are explored as drug carriers, while melanin shows promise in antioxidant and antibacterial formulations. Despite these advances, gaps remain in understanding the mechanistic basis of bioactive compound functions and optimizing cultivation for sustainable production. Future research should integrate multi-omics approaches to elucidate genetic regulation, enhance substrate formulations, and develop value-added products. This review underscores the potential of Auricularia species as a functional food and biotechnological resource, advocating for interdisciplinary efforts to address current challenges and unlock its full industrial potential.
Ergosterol is an important sterol commonly found in edible mushrooms, and it has important nutritional value and pharmacological activity. Ergosterol is a provitamin. It has been well established that edible mushrooms are an excellent food source of vitamin D2 because ergosterol is a precursor that is converted to vitamin D2 under ultraviolet radiation. The pharmacological effects of ergosterol, which include antimicrobial, antioxidant, antimicrobial, anticancer, antidiabetic, anti-neurodegenerative, and other activities, have also been reported. This review aims to provide an overview of the available evidence regarding the pharmacological effects of ergosterol and its underlying mechanisms of action. Their potential benefits and applications are also discussed.
Post-stroke cognitive impairment (PSCI), a common complication following stroke, significantly impacts patients' quality of life and rehabilitation. Recent studies have highlighted the role of gut microbiota and their metabolites in modulating immunoinflammation and cognitive function via the gut-brain axis. Traditional Chinese medicine (TCM) and microbiota interventions including probiotics and fecal microbiota transplantation, have shown potential in reshaping gut microbial communities and metabolite profiles. Some studies suggest that combining these approaches via identical or related therapeutic mechanisms may yield enhanced efficacy in treating Post-Stroke Cognitive Impairment (PSCI). These findings establish a theoretical foundation for future research and clinical practice. This review systematically examines the mechanistic role of gut microbial metabolites in neuroimmune modulation and comprehensively evaluates the therapeutic potential of combined TCM and microbiota-targeted therapies for PSCI, adopting a multifactorial approach that addresses neuroinflammation, microbial dysbiosis, and metabolic dysregulation.
The gut microbiota that exists in the human gastrointestinal tract is incredibly important for the maintenance of general health as it contributes to multiple aspects of host physiology. Recent research has revealed a dynamic connection between the gut microbiota and the central nervous system, that can influence neurodegenerative diseases (NDs). Indeed, imbalances in the gut microbiota, or dysbiosis, play a vital role in the pathogenesis and progression of human diseases, particularly NDs. Herbal medicine has been used for centuries to treat human diseases, including NDs. These compounds help to relieve symptoms and delay the progression of NDs by improving intestinal barrier function, reducing neuroinflammation, and modulating neurotransmitter production. Notably, herbal medicine can mitigate the progression of NDs by regulating the gut microbiota. Therefore, an in-depth understanding of the potential mechanisms by which herbal medicine regulates the gut microbiota in the treatment of NDs can help explain the pathogenesis of NDs from a novel perspective and propose novel therapeutic strategies for NDs. In this review, we investigate the potential neuroprotective effects of herbal medicine, focusing on its ability to regulate the gut microbiota and restore homeostasis. We also highlight the challenges and future research priorities of the integration of herbal medicine and modern medicine. As the global population ages, access to this information is becoming increasingly important for developing effective treatments for these diseases.
No abstract available
No abstract available
Background Tongxieyaofang (TXYF) was a traditional Chinese medicine (TCM) formula for the treatment of diarrhea with liver stagnation and spleen deficiency syndrome, but the potential targets and mechanisms have not been fully clarified. This study aims to explore the potential mechanisms of TXYF in alleviating diarrhea using network pharmacology and full-length 16S rRNA gene sequencing. Methods Network pharmacology was applied to identify bioactive compounds and potential targets involved in the role of TXYF in alleviating diarrhea. Meanwhile, a model of diarrhea with liver stagnation and spleen deficiency syndrome was constructed by intragastric administration of Folium senna extract combined with restraint and tail pinch stress. The effect of TXYF on intestinal mucosal microbiota of diarrhea mice was analyzed by full-length 16S rRNA gene sequencing. Results Network pharmacology analysis showed that kaempferol, wogonin, naringenin, and nobiletin were compounds associated with the efficacy of TXYF. TXYF may alleviate diarrhea via multiple BPs and pathways, including TNF signaling pathway, IL-17 signaling pathway, and Toll-like receptor signaling pathway, which are involved in TCM-gut microbiota-host interactions. Then, we found that TXYF administration reshaped the diversity and composition of the intestinal mucosal microbial community of diarrhea mice. Lactobacillus, primarily Lactobacillus johnsonii, was enriched by the administration of TXYF. After TXYF administration, the abundance of Lactobacillus, particularly Lactobacillus johnsonii, was enriched. Conclusion Oral administration of TXYF may alleviate diarrhea through remodeling intestinal mucosal microbiota. Promoting the colonization of beneficial commensal bacteria in the intestinal mucosa through gut microbiota-host interactions may be a potential mechanism of TXYF in the treatment of diarrhea.
Background Inflammatory bowel disease (IBD) is a refractory inflammatory disorder of the intestine, which is probably triggered by dysfunction of the intestinal epithelial barrier. Secretory leukocyte protease inhibitor (SLPI) secreted by colon epithelial cells protects against intestinal inflammation by exerting anti-protease and anti-microbial activities. Daikenchuto (DKT) is one of the most commonly prescribed Japanese traditional herbal medicines for various digestive diseases. Although several animal studies have revealed that DKT exerts anti-inflammatory effects, its detailed molecular mechanism is unclear. This study aimed to clarify the anti-inflammatory mechanism of DKT using a murine colitis model, and to evaluate its potential as a therapeutic agent for IBD. Methods Experimental colitis was induced in wild-type (WT) mice and SLPI-deficient (KO) mice by dextran sulfate sodium (DSS) after oral administration of DKT. The resultant clinical symptoms, histological changes, and pro-inflammatory cytokine levels in the colon were assessed. Expression of SLPI in the colon was detected by Western blotting and immunohistochemistry. Composition of the gut microbiota was analyzed by 16S rRNA metagenome sequencing and intestinal metabolites were measured by gas chromatography-mass spectrometry analysis. Intestinal epithelial barrier function was assessed by oral administration of FITC-dextran and immunostaining of tight junction proteins (TJPs). Results Oral administration of DKT increased the number of butyrate-producing bacteria, such as Parabacteroides, Allobaculum, and Akkermansia, enhanced the levels of short-chain fatty acids, including butyrate, in the colon, induced SLPI expression, and ameliorated DSS-induced colitis in WT mice. We found that mouse colon carcinoma cell line treatment with either DKT or butyrate significantly enhanced the expression of SLPI. Moreover, supplementation of DKT protected the intestinal epithelial barrier with augmented expression of TJPs in WT mice, but not in KO mice. Finally, the composition of the gut microbiota was changed by DKT in WT mice, but not in KO mice, suggesting that DKT alters the colonic bacterial community in an SLPI-dependent manner. Conclusion These results indicate that DKT exerts anti-inflammatory effects on the intestinal epithelial barrier by SLPI induction, due, at least in part, to increased butyrate-producing bacteria and enhanced butyrate levels in the colon. These results provide insight into the mechanism of the therapeutic effects of DKT on IBD.
ETHNOPHARMACOLOGICAL RELEVANCE Obesity is a common metabolic dysfunction disease, which is highly correlated with the homeostasis of gut microbiota (GM). The dysregulation of GM on energy metabolism, immune response, insulin resistance and endogenous metabolites (e.g., short chain fatty acids and secondary bile acids) can affect the occurrence and development of obesity. Herbal medicine (HM) has particular advantages and definite therapeutic effects in the prevention and treatment of obesity, but its underlying mechanism is not fully clear. AIM OF THE STUDY In this review, the representative basic and clinical anti-obesity studies associated with the homeostasis of GM regulated by HM including active components, single herb and herbal formulae were summarized and discussed. We aim to provide a state of art reference for the mechanism research of HM in treating obesity and the further development of new anti-obesity drugs. MATERIALS AND METHODS The relevant information was collected by searching keywords (obesity, herbal medicine, prescriptions, mechanism, GM, short chain fatty acids, etc.) from scientific databases (CNKI, PubMed, SpringerLink, Web of Science, SciFinder, etc.). RESULTS GM dysbiosis did occur in obese patients and mice, whiles the intervention of GM could ameliorate the condition of obesity. HM (e.g., berberine, Ephedra sinica, Rehjnannia glutinosa, and Buzhong Yiqi prescription) has been proved to possess a certain regulation on GM and an explicit effect on obesity, but the exact mechanism of HM in improving obesity by regulating GM remains superficial. CONCLUSION GM is involved in HM against obesity, and GM can be a novel therapeutic target for treating obesity.
Due to the aging of the population, neurodegenerative diseases (NDs) have gradually become a major public health problem worldwide. Accumulating evidence has demonstrated that the gut microbiota and its metabolites were closely related to the occurrence and development of NDs. At present, Chinese herbal medicine (CHM) is known for its multi-dimensional, multi-target, and multi-pathway approach in the prevention and treatment of various diseases by regulating the gut microbiota, and different CHMs can regulate the diversity of gut microbiota and the abundance of probiotics. Modern studies have also revealed that CHM possessed therapeutic effects against NDs by targeting gut microbiota, regulating the secretion of neuroactive metabolites, reducing amyloid-beta deposition and oxidative stress, and improving the function of the blood-brain barrier. Therefore, the dynamic interaction among CHM, gut microbiota, and NDs has become a research hotspot. This review elaborates on the research progress related to CHM, gut microbiota, and NDs, aiming to provide a new perspective and theoretical basis for the prevention of NDs by CHM administration.
We read with great interest the study by Zhang et al on Yiyi Fuzi Baijiang powder (YFB), which exemplifies the power of modern methods to validate traditional Chinese medicine (TCM). The key insight is that YFB doesn’t merely alter “good” or “bad” bacteria but restores the gut microbiota’s holistic equilibrium. This is powerfully shown by its paradoxical reduction of anaerobic probiotics like Bifidobacterium, rectifying the diseased, hypoxic environment, causing their aberrant overgrowth. This challenges the conventional probiotic paradigm and underscores a core TCM principle: Herbal formulas treat disease by restoring the body’s overall functional balance. Future research should focus on the interplay between herbal components, intestinal oxygen, and microbial metabolites to further unravel this sophisticated dialogue.
Polycystic ovary syndrome (PCOS) is a complex reproductive endocrine metabolic disorder whose pathogenesis remains incompletely understood. In recent years, the role of ferroptosis–a novel form of iron-dependent programmed cell death–in the pathogenesis of PCOS has gradually drawn attention. This review proposes an innovative perspective: gut microbiota dysbiosis may be a potential upstream trigger of ferroptosis in PCOS ovarian granulosa cells. Microbiome dysbiosis disrupts iron homeostasis and reduces the production of antioxidant metabolites such as short-chain fatty acids (SCFAs) and bile acids (BAs), thereby exacerbating systemic and local ovarian oxidative stress. This induces ferroptosis, leading to impaired follicular development and insulin resistance. Traditional Chinese Medicine (TCM) demonstrates significant potential in regulating gut microbiota and inhibiting ferroptosis. Based on this, this study explores the role of the gut microbiota-ferroptosis axis in PCOS, focusing on the scientific rationale and application prospects of treating PCOS by intervening in this axis using TCM monomers and compounds such as berberine and quercetin. With its multi-target regulatory effects and favorable safety profile, TCM may offer benefits as an adjunct or alternative to conventional therapies. This research aims to provide theoretical references for developing novel therapeutic strategies.
It is well-established that there are trillions of gut microbiota (GM) in the human gut. GM and its metabolites can reportedly cause cancer by causing abnormal immune responses. With the development of sequencing technology and the application of germ-free models in recent years, significant inroads have been achieved in research on GM and microbiota-related metabolites. Accordingly, the role and mechanism of GM in colorectal cancer (CRC) development have been gradually revealed. Traditional Chinese medicine (TCM) represents an important source of natural medicines and herbal products, with huge potential as anti-CRC agents. The potential application of TCM to target gut microbes for the treatment of colorectal cancer represents an exciting area of investigation.
Atherosclerosis (AS) is the main cause of cardiovascular disease (CVD) and is characterized by endothelial damage, lipid deposition, and chronic inflammation. Gut microbiota plays an important role in the occurrence and development of AS by regulating host metabolism and immunity. As human mitochondria evolved from primordial bacteria have homologous characteristics, they are attacked by microbial pathogens as target organelles, thus contributing to energy metabolism disorders, oxidative stress, and apoptosis. Therefore, mitochondria may be a key mediator of intestinal microbiota disorders and AS aggravation. Microbial metabolites, such as short-chain fatty acids, trimethylamine, hydrogen sulfide, and bile acids, also affect mitochondrial function, including mtDNA mutation, oxidative stress, and mitophagy, promoting low-grade inflammation. This further damages cellular homeostasis and the balance of innate immunity, aggravating AS. Herbal medicines and their monomers can effectively ameliorate the intestinal flora and their metabolites, improve mitochondrial function, and inhibit atherosclerotic plaques. This review focuses on the interaction between gut microbiota and mitochondria in AS and explores a therapeutic strategy for restoring mitochondrial function and intestinal microbiota disorders using herbal medicines, aiming to provide new insights for the prevention and treatment of AS.
Allergic rhinitis (AR) is a prevalent chronic noninfectious inflammatory disorder. Emerging evidence suggests that the gut microbiota, as a central component of the human microecological system, plays an important role in the development and progression of AR through the gut–nasal axis. Chinese herbal medicine (CHM) has been shown to improve clinical symptoms and quality of life in patients with AR, and these therapeutic benefits may be related to its capacity to modulate gut microbial composition and activity. This review outlines the effects of CHM on the gut microbiota in AR and further explores the possible mechanisms involved.
Abstract: Standardization of herbal formulation is important in order to assess of quality drug. The quality of herbal drug is the considerate all the factor which contribute directly or indirectly to the safety, effectiveness of the product Medicinal plant have been used to improve human health , increasing popularity global as drug , complementary and alternative medicines, food supplement, cosmetic as medical devices. The complexity of herbs and extracts supplied to such a wide range of markets and in different requlatory environment, raise major quality issues, increasing the need for appropriate analytical method for their identification, standardization &also for the detection of adulterants and contamination. Major limitation factors, such as herbal product naming, sampling and sample preparation are also discussed. The use of products of natural origin has remarkably increased in the global market, because of consumer becoming more health-conscious herbal medicines are considered safe by consumers and these product are generally less expensive than allopathic medicines.
While herbal and fruit teas are widely perceived as safe, natural alternatives to caffeinated beverages, emerging research underscores the need for careful evaluation of their safety, toxicity, and regulatory oversight. Unlike conventional teas derived from Camellia sinensis, many herbal and fruit infusions are not subject to uniform global standards, raising concerns regarding quality control, dosage, contamination, and possible drug/herb interactions. Addressing these gaps requires coordinated research efforts that emphasize standardization of phytochemical composition, large-scale clinical trials, and rigorous safety assessments. Thus, long-term toxicological studies and pharmacovigilance systems are needed to establish comprehensive safety profiles for both common and emerging tea ingredients. Such efforts will not only bridge existing knowledge gaps but also position herbal and fruit teas as scientifically validated and globally relevant functional beverages.
Determining the product’s shelf life was necessary to ensure its quality, effectiveness, and safety. This study aimed to determine the stability of moringa tea products. The real-time stability test was carried out at room temperature (28.5‒33.5°C) with 50‒75% relative humidity, and the sampling interval was once every third month (Month-0, Month-3 and Month-6). Physical parameters (organoleptic properties and moisture content), chemical parameters (total phenolic content and total flavonoid content), and microbial parameters (total plate count and total yeast and mould count) were measured using the standard procedures. The organoleptic test showed no changes in colour, taste, smell, and shape of the teabag and brewed tea products up to the sixth month of evaluation. However, there were significant changes in the moisture content (MC), total phenolic content (TPhC), and total plate count (TPC) of the teabag and only in the TPhC of the brewed tea product throughout the quality control. Physical, chemical, and microbial parameters still met the quality requirements set by the Pharmacopoeia Herbal Indonesia and the Indonesian Food and Drug Authority. The qualities of moringa tea bags and brewed moringa teas stored at room temperature (28.5‒33.5°C) and 50‒75% relative humidity showed good physicochemical properties and stability in the test during six months of observation.
Aflatoxins (AFs) are potent mycotoxins classified by the International Agency for Research on Cancer (IARC) as Group 1 human carcinogens. They posed a major safety concern for Chinese herbal medicines (CHMs), potentially compromising both their efficacy and regulatory compliance. Although imported CHMs in Hong Kong are subject to source‐level quality control, inappropriate local storage under the city's warm humid subtropical conditions may facilitate postharvest aflatoxin production. This study aimed to evaluate the influence of storage temperature and humidity on aflatoxin formation in general CHM storage and to investigate additional measures for the prevention and elimination of aflatoxins. Twenty‐two CHMs susceptible to aflatoxin contamination were selected for analysis. The study was conducted in four phases: (1) a market survey to determine baseline aflatoxin and moisture contents; (2) an experimental assessment of aflatoxin formation under different temperature (4°C, 18°C–22°C, and 35°C) and relative humidity (0%–40%, 40%–70%, 70%–90%, and > 90%) conditions over a 24‐month storage period; (3) evaluation of three pretreatment methods—drying, vacuum packaging, and sulfur fumigation—through both accelerated and long‐term stability tests; and (4) a preliminary investigation of ultraviolet (UV) irradiation as a potential aflatoxin detoxification approach. The market survey detected aflatoxin contamination in specific batches of stirred Hordei Fructus Germinatus (Maiya), Eupolyphaga (Tubiechong), Aspongopus Chinensis (Jiuxiangchong), and Nidus Vespae (Fengfang), with one batch of Aspongopus exhibiting severe contamination. Elevated moisture content was common, particularly among animal‐derived CHMs. Storage experiments demonstrated that high temperature (≥ 35°C) and high relative humidity (> 70%) markedly promoted aflatoxin formation. Optimal storage conditions were identified as cool room temperature (< 22°C) and low humidity (< 70%). All three pretreatment methods effectively delayed aflatoxin production for up to 12 months without compromising the integrity of active components. However, certain CHMs, particularly Corydalis Rhizoma (Yanhusuo), remained susceptible after 24 months. Ultraviolet (UV) irradiation (15 W, 1–4 h) at a vertical distance of 30 cm was ineffective in reducing aflatoxin levels in contaminated samples. In conclusion, strict control of storage temperature and humidity is essential to prevent aflatoxin contamination in Chinese herbal medicines. Pretreatment measures, such as drying, vacuum packaging, and controlled sulfur fumigation, demonstrated effectiveness in delaying aflatoxin formation. Further research is warranted to develop feasible and safe detoxification strategies for materials that have already been contaminated.
No abstract available
Abstract Phytopharmaceuticals are the composite mixture of phytoconstituents present in the plants to enable them to produce therapeutic food supplements that could ultimately be used for enhancing human health and wellness by combating illnesses. Botanical-based products are the backbone of the health food market and various types of products have been developed and promoted. Nutraceuticals vary considerably in their chemical nature, physiochemical properties, and biological effects. Many of these nutraceuticals have the potential as functional or medical foods as a means of preventing or treating complex disorders like obesity, geriatrics, cardiovascular diseases. They embrace whole foods with health advantages other than basic nutrition, such as grains, beans, pulses, cereals, fruits, spices, vegetables, tea, coffee, etc. Phytopharmaceuticals should be validated from cultivation in the farm to manufacturing in the industry for quality, safety, efficacy, and regulatory requirements. This chapter highlights several factors involving the development of nutraceuticals and dietary supplements which should be considered for their global acceptance, including efficacy, safety, stability, and regulatory affairs.
This manuscript provides an in-depth review of the significance of quality control in herbal medication products, focusing on its role in maintaining efficiency and safety. With a historical foundation in traditional medicine systems, herbal remedies have gained widespread popularity as natural alternatives to conventional treatments. However, the increasing demand for these products necessitates stringent quality control measures to ensure consistency and safety. This comprehensive review explores the importance of quality control methods in monitoring various aspects of herbal product development, manufacturing, and distribution. Emphasizing the need for standardized processes, the manuscript delves into the detection and prevention of contaminants, the authentication of herbal ingredients, and the adherence to regulatory standards. Additionally, it highlights the integration of traditional knowledge and modern scientific approaches in achieving optimal quality control outcomes. By emphasizing the role of quality control in herbal medicine, this manuscript contributes to promoting consumer trust, safeguarding public health, and fostering the responsible use of herbal medication products.
ABSTRACT Growing health consciousness and aging populations have driven surging demand for traditional and complementary medicines (T&CM), including nutraceuticals, functional foods, and food and medicinal substances (FAMS). Chronic disease burdens and preventive healthcare trends further amplify this growth. However, fragmented regulatory frameworks, inconsistent definitions, and divergent safety evaluation systems across regions hinder global trade and consumer trust. This review compares T&CM governance in China, the United States, the European Union, Japan, South Korea, Australia, India, Russia, African nations, and faith‐based Kosher/Halal certification systems, analyzing legislative milestones and risk management models. Key disparities exist in standardization, ingredient approvals, and evidence requirements. While Asia and the West maintain robust regulations, African countries struggle to align traditional practices with modern safety standards. Emerging technologies such as artificial intelligence (AI)‐powered quality control, multi‐omics‐based validation, and blockchain traceability are critical for ensuring the safety and efficacy of T&CM. The analysis underscores the urgent need for an internationally harmonized regulatory framework, supported by strategic positive/negative ingredient lists and cross‐border cooperation. Policy recommendations emphasize integrating traditional knowledge with scientific validation to optimize market accessibility while ensuring consumer safety. This study's novel contribution lies in its systematic evaluation of T&CM's role in bridging cultural heritage with global public health, offering actionable insights for policymakers to foster equitable trade and innovation in the wellness industry.
No abstract available
Hyperlipidaemia is one of the essential public health risk factors that can cause other metabolic diseases such as cardiovascular diseases and diabetes. Dieting and healthy lifestyle have been among the primary approaches. However, medication is required to regulate the lipid profile in some instances. Therefore, there has been an increase in interest in using or integrating herbal medicine with modern medicine in treating hyperlipidaemia. Nonetheless, preparing standardised herbal extract or products has been one of the major challenges in the herbal industry. Standardising herbal extract or product (single plant-based or mixture of multiple herbs) is needed to ensure the quality, safety, and efficacy of the herbal maintained from batch to batch before it is released to the market. The present review thus evaluates several herbal plants with anti-hyperlipidaemic activities, quality control using chemical markers, and metabolomics application in herbal plants.
Pomegranate (Punica granatum L.) and beetroot (Beta vulgaris) are recognized for their numerous health benefits, attributed to their bioactive. However, the use of natural ingredients as traditional medicine requires attention to microbiological safety, given the potential for contamination by pathogenic microbes. This study aims to analyze microbial contamination on the skin and seeds of white pomegranate (Punica granatum L.) and beetroot (Beta vulgaris). Samples were tested at the Microbiology Laboratory of the Islamic University of Malang using the Total Plate Count (TPC) method to count total microorganisms and qualitative tests to detect the presence of pathogenic microorganisms, such as Salmonella sp. and Staphylococcus aureus. The results showed that the total microbes and mold/yeast for all samples were within the safe limits set by the Food and Drug Administration (BPOM). The highest TPC was found in white pomegranate peel extract (2,1x10⁴ CFU/g), while the highest Total Yeast and Mold Count (TYMC) was found in white pomegranate seed extract (8,2x10⁴ CFU/g). Although Salmonella sp. was not detected in all samples, Staphylococcus aureus was identified positively in white pomegranate seed extract. These findings underscore that, although the total microbial count is low, contamination by specific pathogens can occur, most likely during post-harvest handling. The presence of Staphylococcus aureus highlights the importance of implementing strict sanitation controls and Good Manufacturing Practices (GMP) in the processing of herbal raw materials to ensure product safety.
Objectives This study aimed to present a government-led accreditation system for upgrading the quality control of herbal medicine by introducing the process and evaluation standard of external herbal dispensaries (EHDs) of traditional Korean medicine (TKM) clinics in South Korea 2018 to refer to other countries where herbal medicine were used similarly in Korea. Development Process We organized an EHD accreditation committee for the establishment of an accreditation system. The committee consisted of 9 experts an official of the Ministry of Health and Welfare (MoHW), a professor expert of TKM, a good manufacturing practice expert, a hazard analysis and critical control point expert, and an accreditation system expert. After 3 meetings, a draft of the evaluation standard and evaluation system was established in 2017. Based on the draft, a pilot test was conducted to determine the applicability of the evaluation standards in 2017. Two additional meeting was held to confirm the accreditation standards and was finalized in 2018. Results The evaluation standard for EHDs was developed. In the case of herbal medicine EHDs, the evaluation standard consisted of 9 evaluation categories, 25 evaluation parts, and 81 evaluation items were developed. The results of the evaluation of the pilot tests are as follows, and the results show that there is a deviation between the EHDs. Conclusion As a world’s first, Korea MoHW successfully launched the accreditation system for upgrading the quality control system of herbal medicine not approved by Korea’s Ministry of Food and Drug Safety in 2018. Our report hope to provide a good reference to other countries where having similar herbal medicine system in South Korea hoping to make better quality control of herbal medicines.
BACKGROUND Edible and medicinal herbs1 (EMHs) refer to a class of substances with dual attribution of food and medicine. These substances are traditionally used as food and also listed in many international pharmacopoeias, including the European Pharmacopoeia, the United States Pharmacopoeia, and the Chinese Pharmacopoeia. Some classical formulas that are widely used in traditional Chinese medicine include a series of EMHs, which have been shown to be effective with obvious characteristics and advantages. Notably, these EMHs and Chinese classical prescriptions2 (CCPs) have also attracted attention in international herbal medicine research because of their low toxicity and high efficiency as well as the rich body of experience for their long-term clinical use. PURPOSE Our purpose is to explore the potential therapeutic effect of EMHs with immune-inflammatory modulation for the study of modern cancer drugs. STUDY DESIGN In the present study, we present a detailed account of some EMHs used in CCPs that have shown considerable research potential in studies exploring modern drugs with immune-inflammatory modulation. METHODS Approximately 500 publications in the past 30 years were collected from PubMed, Web of Science and ScienceDirect using the keywords, such as natural products, edible and medicinal herbs, Chinese medicine, classical prescription, immune-inflammatory, tumor microenvironment and some related synonyms. The active ingredients instead of herbal extracts or botanical mixtures were focused on and the research conducted over the past decade were discussed emphatically and analyzed comprehensively. RESULTS More than ten natural products derived from EMHs used in CCPs are discussed and their immune-inflammatory modulation activities, including enhancing antitumor immunity, regulating inflammatory signaling pathways, lowering the proportion of immunosuppressive cells, inhibiting the secretion of proinflammatory cytokines, immunosuppressive factors, and inflammatory mediators, are summarized. CONCLUSION Our findings demonstrate the immune-inflammatory modulating role of those EMHs used in CCPs and provide new ideas for cancer treatment in clinical settings.
Traditional Chinese medicine (TCM) and dietary compounds have a profound influence on the regulation of gut microbiota (GM) in hepatic fibrosis (HF). Certain substances found in both food and herbs that are edible and medicinal, such as dietary fiber, polyphenols, and polysaccharides, can generate beneficial metabolites like short-chain fatty acids (SCFAs), bile acids (BAs), and tryptophan (Trp). These compounds contribute to regulate the GM, reduce levels of endotoxins in the liver, and alleviate fibrosis and inflammation in the liver. Furthermore, they enhance the composition and functionality of GM, promoting the growth of beneficial bacteria while inhibiting the proliferation of harmful bacteria. These mechanisms mitigate the inflammatory response in the intestines and maintain the integrity of the intestinal barrier. The purpose of this review is to analyze how the GM regulates the pathogenesis of HF, evaluate the regulatory effect of TCM and dietary compounds on the intestinal microflora, with a particular emphasis on modulating flora structure, enhancing gut barrier function, and addressing associated pathogenic factors, thereby provide new insights for the treatment of HF.
BACKGROUND Atractylodes macrocephala Koidz. (Baizhu in Chinese, BZ) is a typical traditional edible-medicinal herb used for thousands of years. Known as "the spleen-reinforcing medicine", it is often used clinically to treat reduced digestive function, abdominal distension, and diarrhoea, which are all caused by spleen deficiency. Among BZ's processing products, honey bran-fried BZ (HBBZ) is the only processed product recorded in BZ in the 2020 Chinese Pharmacopoeia (ChP). There are differences in effectiveness, traditional application, and clinical indications between them. PURPOSE This review reviewed BZ and its main product HBBZ from botany, ethnopharmacology, chemical composition, pharmacological effectiveness, and safety. The changes in chemical composition and pharmacological effectiveness of BZ induced by the processing of traditional Chinese medicine were emphatically described. METHODS Keywords related to Atractylodes macrocephala Koidz., honey bran frying, essential oil, lactones, polysaccharide and combinations to include published studies of BZ and HBBZ from 2004-2023 were searched in the following databases: Pubmed, Chengdu University of TCM Library, Google Scholar, China National Knowledge Infrastructure (CNKI), and Wanfang database. All studies, published in English or Chinese, were included. However, in the process of chemical composition collection, we reviewed all available literature on the chemical composition of BZ and HBBZ. CONCLUSION Honey bran frying processing methods will affect BZ's chemical composition and pharmacological effectiveness. The types and contents of chemical components in the HBBZ showed some changes compared with those in BZ. For example, the content of volatile oil decreased and the content of lactones increased after stir-fried bran. In addition, new ingredients such as phenylacetaldehyde, 2-acetyl pyrrole, 6- (1,1-dimethylethyl) -3,4-dihydro-1 (2H) -naphthalone and 5-hydroxymethylfurfural appeared. Both BZ and HBBZ have a variety of pharmacological effectiveness. After stir-fried with honey bran, the "Zao Xing" is reduced, and the efficacy of tonify spleen is strengthened, which is more suitable for patients with weak spleen and stomach.
Background Psoriasis is a chronic inflammatory skin disease mediated by immune dysregulation, with a prolonged course, high recurrence rate, and limited curative options. Biologics are effective but costly, carry immunosuppressive risks, and are associated with relapse after discontinuation. Objective To review the potential mechanisms by which food-derived substances and edible Chinese medicinal materials improve psoriasis through immunomodulation, oxidative stress mitigation, and gut microbiota regulation, and to grade the clinical evidence descriptively. Methods This is a narrative review, not a systematic review. Literature was searched in PubMed, Web of Science, Cochrane Library, CNKI, and Wanfang up to June 2026. Search terms included psoriasis, diet, nutrition, microbiota, metabolism, and Traditional Chinese Medicine. Evidence grading was informed by the GRADE framework, but no formal GRADE assessment was performed. Main Findings The Mediterranean diet and weight-loss interventions have relatively higher levels of evidence. Omega-3 polyunsaturated fatty acids, bioavailable curcumin, specific probiotic strains, and some medicine-food homologous Chinese herbs show potential adjunctive benefits, but most studies are small, single-center, and lack blinding. Traditional applications of honeysuckle, wolfberry, and Coix seed are gradually being explained by modern pharmacology. Conclusion Dietary and medicine-food homologous interventions may serve as adjuncts in psoriasis management but cannot replace conventional treatment. High-quality multicenter RCTs are needed to confirm efficacy and safety.
ETHNOPHARMACOLOGICAL RELEVANCE Chronic pharyngitis persistently afflicts a large population and accounts for approximately one-third of otolaryngology patients. Currently, the treatment of CP remains controversial because of the poor outcomes. Dendrobium officinale is a well-used "Yin-nourishing" traditional Chinese medicinal and edible herb used for thousands of years in China. The flowers of D. officinale are often used in folk of China to make tea for voice protect on and throat clearing. AIM OF THE STUDY This study was to evaluate beneficial effects of polysaccharides from D. officinale flower (DOFP) on CP and its potential mechanisms. METHODS Chemical characterization of DOFP, including polysaccharide content and monosaccharide composition, structural characterization using Fourier transform infrared spectroscopy were performed. A CP model was established in rats by administering a mixture of Chinese Baijiu and chili pepper liquid, combined with low-concentration ammonia spraying. The general states, amount of oral secretion, and apparent state of the pharynx of CP rats were observed during the period of DOFP administration. Furthermore, hemorheological parameters were measured using an automatic hematology analyzer. The levels of tumor necrosis factor-α (TNF-α), interleukin 1β (1L-1β), lipopolysaccharide (LPS), and D-lactate (D-LA) in the serum were measured by enzyme-linked immunosorbent assay. Morphological changes in the pharynx and colon were observed by hematoxylin-eosin staining. The expression of nuclear factor-κB p65 (NF-κB p65), p-NF-κB p65, cyclooxygenase-2 (COX-2), interleukin 1β(IL-1β)and mucin 5AC (MUC5AC) in pharynx,Claudin-1, Occludin, and interleukin 6 (IL-6) in colon was detected by immunohistochemistry and Western Blot. The mRNA expression of TLR4, COX-2, and IL-1β in the pharynx were determined using reverse transcription quantitative real-time PCR. RESULTS In this study, DOFP with a total polysaccharide content of 71.44% and a composition of D-mannose, galacturonic acid, glucose, galactose, and arabinose in a molar ratio of 3.95:2.19:1.00:0.74:1.30, was isolated from the flowers of D. officinale. DOFP improved the general state and exhibited significant effects on reducing oral secretion, alleviating pharyngeal injury, suppressing inflammatory cell infiltration in the pharynx, decreasing the serum levels of TNF-α and IL-1β, and reducing the number of white blood cells and lymphocytes in the model rats. Moreover, the expressions of TLR4, p-NF-κB p65, COX-2, IL-1β and MUC5AC in the pharynx of model rats were obviously inhibited. In addition, the levels of LPS, D-LA in the serum and the protein expression of IL-6 in the colon were downregulated when the protein expression of Occludin and Claudin-1 in the colon were upregulated. CONCLUSIONS DOFP exerts significant ameliorating effects on CP and it likely acts by inhibiting LPS/TLR4-associated inflammatory mediator activation and reducing excessive secretion of MUC5AC by repairing the intestinal barrier in CP rats.
ETHNOPHARMACOLOGICAL RELEVANCE In Traditional Chinese Medicine (TCM), "Jianpi Liqi Huatan" (strengthening the spleen, regulating qi, and resolving phlegm) represents a traditional therapeutic strategy for managing obesity-associated metabolic disorders. According to TCM theory, postmenopausal MS is primarily associated with spleen deficiency, qi stagnation, and phlegm-dampness accumulation. Finger Citron Fruit (FCF), a representative Lingnan medicinal and edible herb and a core herb for Jianpi Liqi Huatan, The correspondence between the traditional properties of FCF and this TCM pathological framework provides an ethnopharmacological rationale for investigating its effects on postmenopausal metabolic dysfunction. AIM OF THE STUDY To explore the metabolic effects and mechanisms of FCF in postmenopausal MS. MATERIALS AND METHODS An ovariectomy (OVX)-induced mouse model, OA&PA-induced primary hepatocytes, and untargeted serum metabolomics were employed to evaluate the therapeutic effects and molecular mechanisms of FCF against postmenopausal MS. RESULTS FCF significantly improved metabolic homeostasis by reducing body weight gain, dyslipidemia, hepatic steatosis, adipose tissue accumulation, and systemic inflammation, while increasing whole-body energy expenditure. Untargeted metabolomics revealed that FCF restored a candidate metabolite putatively annotated as indole-3-acetylglutamic acid. FCF improved hepatic steatosis in association with downregulation of SREBP-1c/ChREBP-related lipogenic signaling and restoration of GPX4 and SLC40A1 expression, thereby alleviating oxidative stress and lipid peroxidation. CONCLUSIONS FCF ameliorated postmenopausal MS by suppressing hepatic lipogenesis and attenuating ferroptosis-related alterations. These findings provide metabolomic and molecular evidence supporting its traditional "Jianpi Liqi Huatan" functions and highlight its therapeutic potential for postmenopausal MS.
Chinese yam is a traditional medicinal herb with a long history of medicinal and edible use in China. Polysaccharides are one of its main active components, possessing biological activities such as immune regulation, anti-tumor, hypolipidemic, hypoglycemic, antioxidant, anti-inflammatory, and antibacterial properties. Recent research has indicated that Chinese yam polysaccharides (CYPs) play a significant role in promoting intestinal health and balancing gut microbiota. The gut microbiota has a direct impact on human digestion, nutrient absorption, energy levels, fat metabolism, and immune system regulation. Moreover, its imbalance can lead to the occurrence of various diseases such as enteritis, diabetes, obesity, tumors, and more. This review provides a brief overview of the extraction, isolation, purification, and structural characteristics of CYPs, with a particular emphasis on their prebiotic benefits, including anti-inflammatory bowel disease, anti-obesity, immune modulation, and anti-inflammatory effects, laying a foundation for future applications of CYPs in the treatment of related diseases.
Sjögren’s disease (SjD) is a chronic autoimmune disorder characterized by progressive dysfunction of the exocrine glands, driven primarily by aberrant T- and B-cell activation. Current therapeutic strategies remain largely symptomatic and are frequently limited by off-target effects and long-term toxicity, underscoring an urgent need for safer, mechanism-based adjunctive approaches. In recent years, nutritional interventions and medicinal herbs have emerged as promising complementary strategies, owing to their capacity to modulate immune–metabolic pathways and restore immune homeostasis. Nutrients such as n-3 polyunsaturated fatty acids (PUFAs) and short-chain fatty acids (SCFAs) exert well-documented anti-inflammatory effects and influence immune cell differentiation via immunometabolic reprogramming. Concurrently, bioactive constituents derived from medicinal herbs offer multi-target regulation of inflammatory signaling and lymphocyte function. This review synthesizes current advances in the immunomodulatory roles of dietary components and edible herbs in the context of SjD, focusing on their mechanistic convergence on T-cell subsets, B-cell responses, and the gut–immune axis. By integrating traditional knowledge with contemporary immunological insights, this article aims to provide a conceptual framework for the rational integration of nutritional and herbal strategies into the clinical management of SjD.
No abstract available
Alzheimer's disease (AD) is the most common neurodegenerative disease. The morbidity of Alzheimer's disease is currently on the rise worldwide, but no effective treatment is available. Cornus officinalis is an herb and edible plant used in traditional Chinese medicine, whose extract has neuroprotective properties. In this investigation, we endeavored to refine a systems pharmacology strategy combining bioinformatics analysis, drug prediction, network pharmacology, and molecular docking to screen tetrahydroalstonine (THA) from Cornus officinalis as a therapeutic component for AD. Subsequent in vitro experiments were validated using MTT assay, Annexin V-PI flow cytometry, Western blotting, and immunofluorescence analysis. In Palmitate acid-induced SK-N-MC cells, THA restored the impaired PI3K/AKT signaling pathway, regulated insulin resistance, and attenuated BACE1 and GSK3β activity. In addition, THA significantly reduced cell apoptosis rate, down-regulated relative levels of p-JNK/JNK, Bax/Bcl-2, cytochrome C, active caspase-3 and caspase-3, and attenuated Palmitate acid-induced Aβ1-42 and Tau generation. THA may regulate the phenotype of AD and reduce cell apoptosis by modulating the PI3K/AKT signaling pathway. This systematic analysis provides new ramifications concerning the therapeutic utility of tetrahydroalstonine for AD.
ETHNOPHARMACOLOGY RELEVANCE In traditional Chinese medicine, Eugenia caryophllyata Thunb. (Clove) is considered warm in nature and pungent in flavor, entering the spleen, stomach, lung, and kidney meridians (In traditional Chinese medicine theory, "meridian tropism" refers to the selective therapeutic effect of a medicinal substance on certain zang-fu organs and meridians of the human body. This herb primarily acts on the spleen, stomach, lung, and kidney, as well as their corresponding meridians). Its core functions are warming the middle to descend counterflow, dispelling cold to alleviate pain, and warming the kidney to assist yang (Through comprehensive regulation of the neuro-endocrine-immune network, it corrects functional decline centered on hypofunction of the hypothalamic-pituitary-target gland axes-including the adrenal, thyroid, and gonadal axes-while also improving energy metabolism, enhancing immunity, and counteracting oxidative stress. In this way, it restores normal physiological function and internal homeostasis at multiple levels and through multiple targets). Traditionally, it is used to treat stomach cold vomiting, hiccups, epigastric and abdominal cold pain, and kidney deficiency impotence. Ancient people often held cloves in their mouths to eliminate bad breath, an effect closely related to its properties of warming the middle to dispel cold and its aromatic qualities for resolving turbidity. AIM OF THE REVIEW A systematic review of Clove is presented herein, encompassing its historical applications, chemical composition, biological effects, and quality evaluation, with further insights into potential areas for subsequent investigation. METHODS Data for this review were gathered from two primary sources: classical texts of traditional medicine (Bencao Gangmu, Dictionary of Chinese Ethnic Medicine) and peer-reviewed scientific databases (PubMed, Web of Science, CNKI). Studies pertaining to the pharmacology, clinical applications, and ethnomedical uses of clove and Eugenia caryophyllata Thunb. were retrieved using relevant keywords and subsequently underwent rigorous critical analysis. RESULT As a traditional interior-warming medicinal, clove is considered in traditional Chinese medicine theory to be warm in nature and pungent in flavor, entering the spleen, stomach, lung, and kidney meridians. Its core efficacies are warming the middle to descend counterflow, dispelling cold to alleviate pain, and warming the kidney to assist yang. Traditionally, it is used for conditions such as stomach cold vomiting, hiccups, toothache, and impotence. Modern research indicates that its main chemical components are volatile oils (predominantly eugenol, with content reaching 15%-20%) along with non-volatile constituents such as flavonoids and tannins. Its pharmacological effects include antibacterial and anti-inflammatory actions (inhibiting periodontal pathogens and Helicobacter pylori), regulation of digestion (bidirectional regulation of gastrointestinal motility), antioxidant activity, analgesia, and inhibition of osteoclast activation. In terms of quality control, traditionally, those with large size, high oil content, and strong aroma were considered superior. The current Pharmacopoeia of the People's Republic of China uses a eugenol content of not less than 11.0% as the core indicator. Future research needs to further refine the multi-index composite quality evaluation system and deeply elucidate the mechanisms of action of its bioactive components. DISCUSSION Current research on clove faces several limitations: a single quality evaluation index relying solely on eugenol content, an unclear pharmacodynamic material basis, fragmented understanding of its mechanisms of action, and developmental bottlenecks in resource utilization due to the poor stability of eugenol. Future prospects include constructing a knowledge graph that integrates multi-source data to explore the "medicinal material-component-target" associations; deepening research on bioactive substances and mechanisms, such as investigating the regulation of transient receptor potential (TRP) channels; refining a multi-index composite quality evaluation system; and making breakthroughs in technologies like nano-encapsulation to expand its applications in daily chemical products such as oral care and antibacterial gels. Overall, the goal is to transition from fragmented data to systematic knowledge, promoting quality standardization and industrial diversification.
Abstract As a traditional medicinal and edible herb, Danggui (Angelicae Sinensis Radix) exhibits pharmacological activities closely associated with its characteristic chemical components, such as volatile oils (e.g., ligustilide), organic acids (e.g., ferulic acid), and polysaccharides. It demonstrates a wide range of pharmacological effects, including anti-inflammatory and immunomodulatory properties, cardiovascular and cerebrovascular protection, neuroprotective functions, blood glucose regulation, antitumor activity, and hematopoietic promotion. Clinically, Danggui (Angelicae Sinensis Radix) is often combined with other Chinese herbs to treat immune-related disorders, cardiovascular and cerebrovascular diseases, neurodegenerative conditions, diabetes, and cancer. Although existing studies have identified some active components, the mechanisms and pharmacological roles of many others remain underexplored. Future research should focus on systematically analyzing diverse active constituents such as flavonoids, coumarins, amino acids, bioactive peptides, trace elements, and vitamins. Integrating multiomics and molecular docking technologies will help elucidate key targets and molecular mechanisms underlying its anti-inflammatory, antioxidant, and immunomodulatory effects, thereby facilitating the development of precise therapies based on multicomponent synergy. Additionally, in-depth investigation of herb-pairing effects and establishment of scientific quality control standards are essential to expand clinical applications and enhance the medicinal value of this traditional herb.
Anoectochilus roxburghii (Wall.) Lindl. (AR) is a perennial herb that has long been used as medicinal and edible plant. In Traditional Chinese Medicine (TCM), AR is utilized to treat various diseases including hyperuricemia, type 2 diabetes mellitus, cancers and inflammatory diseases. Recent advances in the discovery and isolation of bio-active compounds have unveils the main medicinal ingredients, such as quercetin, kinsenoside and rhamnazin. Pharmacological studies further demonstrated its activities, containing anti-inflammation, anti-oxidation, and antihyperlipidemia effects. The processed AR products have various commercial applications in functional foods and cosmetics. AR has been used to prepare soup, drinkbeverage, jelly, face masks, soap, etc. However, despite the abundant medicinal value, it hasn't been included in the 2020 Chinese Pharmacopoeia up to now. There is also no consistent evaluation standard across provinces. This seriously affects the safety and the efficacy of TCM prescriptions, not to mention the development question. This review summarizes recent research on AR in phytochemistry, pharmacology, quality control and applications, raises the corresponding solutions to provide references and potential directions for further studies.
ETHNOPHARMACOLOGICAL RELEVANCE Artemisia anomala S. Moore (family: Asteraceae) is a traditional herb that has been used for medicinal purposes in China for more than 1300 years. In traditional and local medicine, A. anomala is widely used in the treatment of rheumatic, dysmenorrhea, enteritis, hepatitis, hematuria and burn injury, and it is also considered as a natural botanical supplement in some areas, a traditional herb with both medicinal and edible properties. AIM OF THE REVIEW The paper aims to provide a comprehensive overview of A. anomala, covering its botany, traditional uses, phytochemistry, pharmacological activity, and quality control, and to summarize the current research status in order to better understand the application value of A. anomala as a traditional herbal medicine and provide references for its further development and utilization. MATERIALS AND METHODS The relevant information on A. anomala was collected by searching a range of literature and electronic databases using "Artemisia anomala" as the key search term. These sources included both ancient and modern books, the Chinese Pharmacopoeia, as well as various online databases such as PubMed, ScienceDirect, Wiley, ACS, CNKI, Springer, Taylor & Francis, Web of Science, Google Scholar, and Baidu Scholar. RESULTS At present, 125 compounds have been isolated from A. anomala, including terpenoids, triterpenoids, flavonoids, phenylpropanoids, volatile oils and other compounds. Modern studies have confirmed that these active components have significant pharmacological activities, including anti-inflammatory, anti-bacterial, hepatoprotective, anti-platelet aggregation and anti-oxidation. In modern clinic, A. anomala is widely used in the treatment of rheumatoid arthritis, dysmenorrhea, irregular menstruation, traumatic bleeding, hepatitis, soft tissue contusion, burn and scald. CONCLUSIONS Long-term traditional medicinal history and a large number of modern in vitro and in vivo studies have confirmed that A. anomala has a wide range of biological activities, which can provide rich resources for the discovery of promising drug candidates and the development of new plant supplements. However, the research on the active components and molecular mechanism of A. anomala is insufficient, and more mechanism-based pharmacological evaluation and clinical research should be carried out to provide a more powerful scientific basis for its traditional use. In addition, the index components and determination standards of A. anomala should be established as soon as possible, so as to establish a systematic and effective quality control system.